Substance P receptor on human astrocytoma cells: biochemical and pharmacological studies. by Tung, Wai Lin. & Chinese University of Hong Kong Graduate School. Division of Biochemistry.
SUBSTANCE PRECEPTOR ON HUMAN ASTROCYTOMA CELLS. 
BIOCHEMICAL AND PHARMACOLOGICAL STUDIES. 
BY 
TUNG WAI LIN 
B. Se. (Han. ) I C. U • H. K. 
A THESIS SUBMITTED IN PARTIAL FULFILMENT OF 
THE REQUIREMENT FOR 
THE DEGREE OF MASTER OF PHILOSOPHY IN BIOCHEMISTRY 
JUNE 1990 
DEPARTMENT OF BIOCHEMISTRY 
THE CHINESE UNIVERSITY OF HONG KONG 
- / ') ( 
316406 
ocr !d l 
.f'" 
TABLE OF CONTENTS 
ACKNOWLEDGEMENT 
LIST OF ABBREVIATIONS 
ABSTRACT 



















TAURINE IN THE CNS 
General metabolism of taurine 
Release and uptake of taurine 
by neurons and glia 
Taurine uptake 
Taurine release 
FUNCTIONS OF ASTROCYTES 
Potassium homeostasis 
Water homeostasis 
NEURON-GLIA COMMUNICATION : NEURO-
TRANSMITTER RECEPTORS AND SECOND 
MESSENGER SYSTEMS IN ASTROCYTES 
Adenylate cyclase pathway 
Inositol lipid pathway 
InS(1,4,5)P3/ca2+ pathway 
DAG/PKC pathway 
Dual actions of PKC 
Interaction between second 
messenger systems 
SUBSTANCE PRECEPTOR ON ASTROCYTES 
SP and SP receptors 
Evidence for the existence of SP 













































IN VITRO CULTURE OF HUMAN 
ASTROCYTOMA CELLS (U-373 MG) 
Preparation of reagents 
Culture of astrocytoma cells 
Cell plating In 24-well plastic 
trays 
DETERMINATION OF [3HJ-TAURINE 
RELEASE 
Physiological salt solution (PSS) 
Preparation of working [3 H]-
taurine solution 
Assay of [3HJ-taurine release 
Drug pretreatment 
Data analysis 
DOWN REGULATION OF PKC ACTIVITY 
BY PROLONGED PMA PRETREATMENT 
Preparation of working Phorbol-
12-myristate-13-acetate (PMA) 
solution 
Pretreatment of cells with PMA 
DETERMINATION OF cAMP 
Drugs effects on cAMP 
Data analysis 
MEASUREMENT OF INOSITOL PHOSPHATES 
Downx column preparation 
Determination of total inositol 
phosphates accumulation 
Column separation 
Determination of inositol 
trisphosphate (IP3 ) 












































Preparation of cytosolic and 
membrane bound PKC 
Reagent preparation 
Preparation of DEAE-cellulose 
column 
Protocol of preparing cytosolic and 
membrane bound PKC 
PKC assay 
Reagent preparation 
PKC activity assay protocol 
STATISTICAL METHOD 
SOME CHARACTERISTICS OF TAURINE 
TRANSPORT IN U-373 MG ASTRO-
CYTOMA CELLS 
Time and sodium dependence of 
taurine uptake 
Time dependence of SP-stimulated 
taurine release 
Effect of ions on SP-stimulated 
taurine release 
Effect of sodium on taurine release 
Effect of potassium on taurine 
release 
Effect of calcium and magnesium 
on taurine release 
Tem~erature-dependence of 
[ H)-taurine release 
Comparison of chemical-induced 
release of taurine and GABA 
from U-373 MG astrocytoma cells 
PHARMACOLOGICAL STUDIES OF 
SP-STIMULATED TAURINE RELEASE 
Effect of mammalian tachykinins 
and their analogues on the 







































Antagonistic effec~ of spantide on 
SP-stimulated [H)-taurine release 51 
The interaction between SP- and 
IPR- stimulated taurine release 55 
concentration dependencJ of IPR-induced release of [H)-taurine 55 
Effect of 100 nM IPR on SP-stimulated 
taurine release 
SECOND MESSENGER SYSTEMS INVOLVED IN 
THE REGULATION OF TURINE RELEASE BY 
55 
SP AND IPR 55 
The role of cAMP 58 
The role of phosphatidylinositol 
bisphosphate (PIP2 ) metabolism 58 
Time course of SP-induced inositol 
phosphates accumulation 61 
Pharmacological studies of SP-induced 
IPs accumulation 61 
Effect of SP on inositol trisphosphate 65 
Effect of IPR on IPs accumulation 
The role of Ca 2+ mobilization 
The role of protein kinase C (PKC) 
Concentration dependence of 
PMA-stimulated taurine release 
Effect of H7 on the release of 
taurine 
Effect of staurosporine on taurine 
release 
Effect of chronic PMA pretreatment 









CHAPTER 4 DISCUSSIONS 90 
4.1 A COMPARISON OF THE CHARACTERISTICS 
OF TAURINE RELEASE FROM ASTRO-






SP-INDUCED [3HJ-TAURINE RELEASE 
FROM U-373 MG ASTROCYTOMA CELLS 93 
THE ROLE OF SECOND MESSENGER SYSTEMS 
IN THE SP-INDUCED [3HJ-TAURINE 
RELEASE 95 
BIOLOGICAL SIGNIFICANCE OF SP-INDUCED 




I wish to express my sincere gratitude to my 
supervisor Dr. C.M. Lee who introduces me into this 
field of research. His expertise advices, harsh but 
constructive criticism, enthusiastic discussion offer 
me such insight in my field of study. 
I am also thankful to Prof. J. D. Young for his 
stimulating enthusiasm and constant discussion in my 
work. 
My special thanks are due to D:r. K.N. Leung and 
Mr. K.C. Yu for their advice on my cell culture 
techniques. 
I also wish to express my heartful thanks to 
Mr. W. W. Choi for secretarial help and excellent 
computer technical assistance in preparing this thesis 
and Dr. S.K. Kong, Ms. M. Look, and Ms. P.Y. Chu for 
their help and encouragement throughout the project. 



























bovine serum albumin 
cyclic adenosine 3 1 ,5 1 monophosphate 
diacylglycerol 
dimethylsulfoxide 

















phosphate buffered saline 










2 , 2'-p-phenylenebis(5-phenyloxazole) 
2,5-diphenyloxazole 
phosphatidylserine 





The basal release of [3HJ-taurine from human astrocytoma 
(U-373 MG) cells was independent of extracellular calcium and was 
not increased by a high concentration of potassium (40 mM). These 
properties clearly distinguished them from the calcium-dependent, 
depolarization sensitive taurine release from neurons. According 
to the pharmacological studies, substance P (SP) stimulated 
taurine release was a receptor mediated event. 
Substance P (SP) and two other mammalian tachykinins, neurok-
inin A (NKA) and neurokinin B (NKB) were found to stimulate the 
release of [3HJ-taurine from human astrocytoma (U-373 MG) cells 
with an EC SO of 0.3, 20 and 200 nM respectively. Moreover, two 
synthetic SP hexapeptide analogues, [Glp6, D-pro9 J-SP(6-11) and 
[Glp 6, L-pro9 J-SP(6-11) also stimulated [3 H]-taurine release with 
an ECso of 3.6 ~M and 20 nM respectively. The rank order of 
potencies of tachykinins and their analogues in stimulating the 
release of [3 H]-taurine from human astrocytoma (U-373 MG) cells 
suggests that this effect was mediated via an NK-l subtype of 
tachykinin receptor. Spantide, a SP receptor antagonist, at 
concentrations of 1 ~M and 10 ~M, dose-dependently inhibited the 
effect of SP on [3HJ-taurine release. 
The activation of NK-1 receptor on U-373 MG cells by SP was 
accompanied by an increase in the accumulation of inositol phos-
phates (IPs) and inositol trisphosphate (IP3 ), presumably as a 
result of hydrolysis of phosphatidylinositol bisphosphate (PIP2 ) \ 
by phospholipase C. The potency of SP and NKA in stimulating 
[3HJ-inositol phosphates accumulation correlated very well with 
1 
their effects in stimulating the release of taurine. Moreover, 
spantide also concentration dependently inhibited the effect of 
SP on IPs accumulation. 
The increase in IP3 accumulation induced by SP may regulate 
taurine release through an increase in intracellular calcium. The 
fact that A23187 can stimulate [3HJ-taurine release in a calcium 
dependent manner provided an indirect evidence for it. The hy-
drolysis of PIP2 should also generate diacylglycerol (DAG) which 
in turn can stimulate the activity of protein kinase C (PKC). The 
role of PKC in the regulation of taurine release was supported by 
the fact that phorbol-12-myristate-13-acetate (PMA), a PKC acti-
vator, can stimulate taurine release from U-373 MG cells. It was 
suspected that PKC may also play a role in SP-induced taurine 
release since after 1 min exposure to SP (100 nM), some PKC 
activity in the cytosolic fraction was translocate to the mem-
brane-bound fraction and resulted in an activation of the enzyme. 
Indeed, SP-induced taurine release could be inhibited by stauros-
porine, a potent PKC inhibitor. Moreover, SP-stimulated taurine 
release was inhibited if the cells were depleted of PKC by pre-
treatment with 10 ~M phorbol-12-myristate-13-acetate (PMA) for 19 
h. 
In addition to SP, isoproterenol (IPR) was also found to 
stimulate [3HJ-taurine release but its response seemed to be 
mediated by a cAMP pathway. It appeared that there was no cross-
talk between the cAMP/adenylate cyclase and IP3/PLC pathway in 
the U-373 MG astrocytoma cells. These three different lines of 
experimental evidence in support of this conclusion: 
2 
(1) IPR (100 nM) did not alter the basal and SP-induced [3 H]-
inositol phosphates accumulation while SP (1 MM) did not change 
the basal and IPR-induced cAMP accumulation; 
(2) chronic PMA pretreatment decreased SP-induced taurine release 
but not the IPR response; 




CHAPTER ONE. INTRODUCTION 
1.1 TAURINE IN THE CENTRAL NERVOUS SYSTEM 
Taurine (2-aminoethanesulfonic acid) is widely distributed in 
animal organs and is particularly abundant in excitable tissues, 
ranging in concentration from 5 to 20 ~moles/g in the muscle and 
heart and from 1 to 11 Mmoles/g in the brain of different species 
(Mandel & Pansantes-Morales, 1973). Although the regional distri-
bution of taurine in the brain is rather even, higher than aver-
age levels are found in the pituitary and pineal glands, retina, 
cerebellum, olfactory bulb and striatum (Mandel & Pasantes-
Morales, 1978). Immunocytochemical studies on the rat cerebellum 
have revealed the presence of taurine-like immunoreactivity in 
several types of neurons including the Purkinje, stellate and 
granule cells and also in astrocytes (Chan-Palay et. al., 1982; 
Madsen et. al., 1985). 
1.1.1 GENERAL METABOLISM OF TAURINE 
Despite the ubiquity of taurine in mammals, a number of 
higher animals have lost the ability to synthesize it in amounts 
sufficient to maintain their body level .. Such species, which in-
clude cat and man, have to rely on the dietary source of taurine. 
In species that do make taurine, the major site of synthesis is 
the liver and synthesis within the central nervous system (CNS) 
is of little metabolic importance (Huxtable, 1989). Whole animal 
balance studies in the mouse and rat have established that a 
considerable percentage of taurine in the brain is derived from 
the diet and it reaches the brain via a specific transport mecha-
nlsm (Huxtable, 1981). Taurine is a metabolically relatively 
inert substance which seems to undergo little incorporation into 
proteins and is not catabolized. The body levels are regulated by 
species-specific excretion via the liver (taurocholic acid) and 
kidney (Van Gelder, 1978). 
1.1.2 RELEASE AND UPTAKE OF TAURINE BY NEURONS AND GLIA 
Taurine transport in the eNS has been studied in vivo (Wheler 
et. al., 1977), in brain slices(Kaczmarek & Davison, 1972), ln 
cultured neuronal and glial cells (Holopainen, 1988; Holopainen 
et. al., 1987) and in synaptosomes (Meiners et. al., 1980). 
1.1.2.1 TAURINE UPTAKE. 
It has-been demonstrated that the taurine uptake systems in 
neurons and astrocytes are similar in that they are strictly 
sodium-dependent (Holopainen et. al., 1987; Yuasa & Hamprecht, 
1987) . 
Schousboe and coworkers (1976) have demonstrated that glial 
cells have greater transport capacity f9r taurine than neurons 
(Schousboe et. al., 1976). On the other hand, Holopainen and 
coworkers (1987) have reported that granule cells and astrocytes 
have similar capacity to transport taurine. This discrepancy may 
be due to the heterogeneity of astrocytes (Wilkin et. al., 1990) \ 
which lead to the regional difference of taurine uptake in the 
brain. Hanretta and Lombardini (1987) have. reported a differen-
5 
tial uptake and compartmentalization of taurine by neuronal and 
glial cells from the rat hypothalamus. They proposed a neuronal 
location for the high affinity taurine uptake system and a glial 
location for the low affinity uptake system. The possible func-
tion of the high affinity uptake system is to rapidly remove 
extracellular synaptic taurine released by taurine containing 
neurons in order to limit the duration of the action of taurine 
on postsynaptic receptor sites. The low affinity uptake of tau-
rine by glial cells may function to remove taurine that diffuses 
away from the synaptic cleft. 
1.1.2.2 TAURINE RELEASE 
Davidson (1979) reported that in the in vivo superfusate of 
anaesthetized rat cerebellar cortex, high K+ (40 mM); rectangu-
lar, 0.1 msec electrical pulse at 1.5 mA and 500 Hz; a depolariz-
ing alkaloid veratridine (0.5 x 10-5 M) or scorpion venom (~g/ml) 
can all stimulate taurine release. Both the high K+ and 
electrically evoked taurine effluxes were markedly calcium de-
pendent. The veratridine response was abolished in the presence 
of tetradotoxin (~g/ml). It was concluded that taurine was being 
released from excitable cells rather than from neuroglia and may 
have some neurotransmitter-like role in the cerebellum. 
Taurine was also released by depolarization from cerebellar 
slices and synaptosomal preparations, but the cell type contrib-
uting to the release was not determined (Bernardi et. al., 1984; 
Okamoto et. al., 1978). Recently, Oja and Kontro (1987) also 
6 
demonstrated the release of both taurine and GABA from mous e 
cerebral cortex slices by a depolarizing concentration (50 mM) of 
The K+-stimulated taurine and GABA release were calcium 
dependent and magnesium can antagonise this ca2+ dependent re-
lease. 
Taurine can also be released from cultured neurons in re-
sponse to a depolarizing stimulus. However, the properties of 
taurine release from these neurons were clearly different from 
that of GABA and glutamate release (Schousboe & Pasantes-Morales, 
1989). The release of GABA and D~asparate (a non-metabolizable 
analogue of glutamate) stimulated by K+ (56 mM) was rapid in 
onset and declined quickly to baseline despite the continual 
presence of the depolarizing agent. The efflux of taurine, on the 
other hand, was much lower in magnitude and showed a delay in 
attaining the peak stimulation followed by a very slow return to 
the baseline. The taurine release showed little or no calcium 
dependence but a marked chloride dependence. They concluded that 
the taurine release may represent a cell response different from 
the stimulus-secretion coupling of neurotransmitters. More re-
cently, K+ has been shown to stimulate [3 H]-taurine release from 
astrocytes as well (Holopainen et. al., 1989; Pansantes-Morales 
et. al., 1988). 
1.2 FUNCTIONS OF ASTROCYTES 
Astrocytes comprise about 25% the cellular volume of the 
brain (Lomneth et. al.,1989). The star-like shape of astrocytes 
" ' 
serves to distinguish them from other glial cells. In vitro they 
7 
can also be distinguished biochemically from other brain cells by 
the presence of the intermediate filament protein, glial fibril-
lary acidic protein (GFAP), S-100 protein and glutamine synthe-
tase (Root, 1981; Brock, 1975; Bignami et. al., 1972). The dis-
tinctive electrophysiological properties of astrocytes include a 
resting membrane potential of about -70mV which has been shown to 
be almost purely K+ dependent in guinea pig and human (Picker et. 
al., 1981). In contrast to neurons, astrocytes do not generate 
action potentials in response to short depolarizing electrical 
current (Moonen et. al.,1980). 
Although astrocytes have been known since the late 19th 
century, the function of mature astrocytes in the CNS and the 
influence of neurochemicals on these cells have been extremely 
difficult to define. They are thought to participate in the 
following functions: formation of blood brain barrier and regu-
late the exchange of materials between capillaries and neurons, 
biochemical modulation of synaptic activity, guiding of neuronal 
processes during development and possibly during repair, a reser-
voir for K+ and water, some phagocytic activity and structural 
support for nervous tissue (McGeer et. al., 1987). For the 
present study we are particularly interested in the role of 
astrocytes in potassium and water homeostasis in the brain. 
1.2.1 POTASSIUM HOMEOSTASIS 
The stability of the extracellular fluid in the CNS is very 
important because otherwise the signal transmission and integra-
tion of activity in the cerebral tissues might be disturbed. As a 
8 
result of neuronal activities large amounts of K+ are released 
from neurons to the intercellular space. Extracellular K+ that 
accumulates around neuronal membranes will tend to increase 
neuronal excitability and alter synaptic transmission. In order 
to maintain normal neuronal function, the regulation of extracel-
lular potassium level in the CNS is essential (Sykova, 1983). 
Hertz (1978) has directly measured uptake (influx) of K+ 
into astrocytes in vitro at different external K+ concentra-
tions. Astrocytes in primary cultures have been postulated to 
possess three different mechanisms which seem to be involved in 
K+ homeostasis in the CNS, including: 
(1) an active uptake catalyzed by the Na+/K+-ATPase (Henn et. 
al., 1972) 
(2) K+, CI- cotransport or Na+, K+, Cl- cotransport (Kimelberg & 
Frangakis, 1985; Walz & Hertz, 1984) 
(3) a current-carried redistribution of K+ when the cells are f 
exposed to a local increase in the concentration of K+ (spatial I 
! 
buffering). Potassium spatial buffering depends on the very high ,1 
\ 
selective permeability of the glial membrane to potassium and the 
existence of glial cells as a syncytium (Gardner-Medwin, 1986). 
1.2.2 WATER HOMEOSTASIS 
For normal brain function, water homeostasis is very importan~ 
The brain have a high glucose consumption rate and the metabolism 
of glucose will produce large amount of metabolic water. The 
neurons must develop a mechanism to get rid of this water in 
9 
order to maintain a constant intracellular osmolarity (Van Gelder 
& Barbeau, 1985). Taurine is metabolic inert, neutral in charge, 
high in solubility, and can be sequestered in high concentra-
tions. Indeed, it is present in high concentrations (1-2 mmol/kg 
fresh weight of neural tissue) in both glial cells and neurons 
(Van Gelder and Barbeau, 1985). Hence, it may play a role in 
osmoregulation in the brain. Since neurons have a less de-
veloped capacity to store taurine than do glial cells, it has 
been hypothesized that astrocytes may play a more important role 
in water homeostasis in the brain (Walz & AlIen, 1987). Indeed, 
when cultured astrocytes are exposed to hypo-osmotic medium, they 
initially swell and then return to their normal volume and 
taurine can be released (Pansante Morales & Schousboe, 1988). 
The authors suggested that taurine participated in astrocyte 
volume regulation as an osmoeffector. Van Gelder (1989) " has 
postulated that the dynamic flux of taurine between neuron and 
glia is very important for the osmotic regulation of water de-
rived from glucose metabolism. 
A malfunction of astrocyte volume control may lead to cere-
bral edema (Olson et. al., 1989). Moreover, astrocytic swelling 
accompaning a number of pathological conditions including hypo-
glycemia, status epileptics, ischemia, head trauma, and hepatic 
encephalopathy have been reported (Long, 1984). Therefore, it is 
very important to understand the mechanism of astrocyte volume 
regulation. Recently, receptors for a number of neurotransmitters 
including isoproterenol, adenosine and serotonin have been found 
on astrocytes (Martin et. al.,1988). Moreover, activation of 
these receptors stimulate taurine release from glial cells which 
10 
in turn may regulate water homeostasis in the brain. 
1. 3 NEURON-GLIA COMMUNICATION: NEUROTRANSMITTERS RECEPTORS AND 
SECOND MESSENGER SYSTEMS IN ASTROCYTES 
Although the functions of most neurotransmitter receptors on 
astrocytes is not yet known, their presence indicate that astro-
cytes are far from being passive architectural elements, but may 
respond to changing brain conditions in as complex a way as 
neurons do. Some of the transmitters that increase either cAMP or 
phosphatidylinositol metabolism can also increase the phosphory-
lation of glial fibrillary acidic protein (McCarthy et. 
al.,1988). other properties of cultured astrocytes that have been 
reported to be altered by receptor stimulation include membrane 
potential (Marrero et. al., 1989), taurine release (Madelian et. 
al., 1985) and cell morphology (Narumi, 1978). 
The activation of cellular function and proliferation are 
frequently initiated by the interaction of external stimuli with 
their specific cell-surface receptors. The information detected 
by cell surface receptors is transduced into the cell through 
second messengers to activate a whole variety of cellular re-
sponses. The number of second messengers is relatively small and 
the cellular signal pathways are remarkedly universal (Berridge 
1986; Gilman, 1984). Different second messenger systems have 
been demonstrated in cuI tured astrocytes and glioma cell lines 
/ 
(Pearce & Murphy, 1988). The activation or down-regulation of 
these second messenger systems may play a role in the regulation 
of intracellular events. 
11 
1.3.1 ADENYLATE CYCLASE PATHWAY 
Adenylate cyclase system consists of at least three types of 
proteins embedded in the lipids of the plasma membrane: receptor, 
guanine-nucleotide-binding protein (G-protein) and adenylate 
cyclase. Activated adenylate cyclase (AC) converts ATP to cAMP. 
cAMP binds to the regulatory component of its protein kinase (A 
kinase), liberating the catalytic component which is then free to 
phosphorylate specific proteins to regulate various cellular 
responses. Two different G-proteins (Gs and Gi) which different 
in their a subunit (as and ai)' mediate the effects of receptors 
that stimulate or inhibit adenylate cyclase activity respectively 
(Taylor & Merrit, 1986). The a subunits also contain intrinsic I 
GTPase activity that has been proposed to be a major pathway for 
G-protein inactivation (Neer & Clapham, 1988). Up to now, the G 
protein family has been expanded to at least nine members. They 
I 
I 
form complex regulatory pathways to co-ordinate various . t I ln ra- , 
I 
cellular events (sternweis & Pang, 1990; Wagner et. al.,1990). 
1.3.2 INOSITOL LIPID PATHWAY 
Activation of a family of ca2+-mobilizing receptors stimu-
lates phospholipase C (PLC) -mediated hydrolysis of phosphatidy-
linositol 4,5-bisphosphate to form inositol l,4,5-trisphosphate 
[Ins(l,4,5)P3 J and diacylglycerol (DAG) (Berridge, 1984, 1987; 
Hokin, 1985; Hirasawa, 1985). Multiple isozymes of PLC have been 
demonstrated which are linked to guanine nucleotide binding 
12 
proteins (Ross et. al., 1989; Taylor & Merritt, 1986) . 
[Ins(l,4,S)P3 J and DAG have been shown to be important intracel-
lular messengers. The primary function of Ins(l,4,S)P3 is to 
mobilize calcium from intracelluar stores (Berridge, 1984b) to 
constitute an Ins(l,4,S)P3/ca2+ pathway, whereas DAG stimulates 
protein kinase C (PKC) (Nishizuka, 1984) to form a DAG/PKC path-
way (Fig 1.1). 
2+ 1.3.2.1 InS(1,4,S)P3/ca PATHWAY 
. • • I Increase of lntracellular Ins(l,4,5)P3 causes an lncrease .In 
cytosolic free Ca 2+ from both internal and external sources. 
The initial response to stimulation by ca2+-mobilizing agonists 
is a release of internal ca2+ (phase I), which is soon followed I 
1 
by entry of Ca2+ across the plasma membrane (phase 11) (Berridge, ; 
2 1 1 1987). Removing external Ca + usually has no effect on phase I, 
but severely curtails phase II-response (Reynold & Dubyake, 
1985). Ins(1,4,S)P3 functions to release ca2+ from the endoplas-
mic reticulum. It acts through a specific receptor which is 
/ either connected to or is an integral part of a putative ca2+ 
channel (Berridge, 1987). Of the inositol phosphates tested, only 
those having phosphates on the 4- and S- positions are capable of 
stimulating ca2+ release (Downes, 1988). 
Inositol polyphosphates (IP3 , IP4 , IPS and IP6 ) may be a 
family of signal molecules. Possibly, each of these metabolites 








































































































































































































































































































channels in the plasma membrane (Downes, 1988; Fink & Kaczmarek, 
1988). One pathway for metabolizing Ins(1,4,5)P3 depends on a 
series of dephosphorylation reactions that cUlminates in the 
formation of free myo-inositol (Berridge, 1987). In the other 
pathway, Ins(1,4,5)P3 is transformed into alternative polyphos-
phates before being dephosphorylated. There are indications that 
the DG/PKC pathway may act to stimulate the hydrolysis of 
Ins(l,4,5)P3 (Molino et. al., 1986; Connolly et. al., 1986). 
Recent experiments indicate that in excitable tissues a rise in 
cytosolic Ca 2+ can also activate the PLC (Eberhard & Holz, 1988). 
Therefore, a rise in cytosolic ca2+ may act as a positive feed-
back signal for PLC. 
Following termination of the initial stimulus, cytosolic Ca 2+ 
would return to the resting level through sequestration in orga-
i 
nelles such as mitochondria and through efflux across the plasma l 
I 
membrane. In addition, elevated intracellular ca2+ may decrease rl 
. 11 
of IP3 to release sequestered Ca2+ (Chueh & Gill/ l/ 
inhibit PLcl 
the ability 
1986) . Furthermore, PKC activation by DAG may 
! 
activity through a negative feedback loop (Orellana et. al., ; 
1985; Broch et. al., 1985). 
1.3.2.2 DAG/PKC PATHWAY 
Protein kinase C (PKC), a serine/threorine protein kinase, is 
thought to play a major role in the control of a wide variety of 
cellular processes which include secretion, contraction, membrane 
receptor function, cell differentiation and tumor promotion 
(Nishizuka, 1986; Kaczmarck, 1987). It is a ca2+-activated and 
15 
phospholipid-dependent protein kinase (Takai et. al., 1979a). DAG 
and phorbol ester can stimulate PKC activity directly (Nishizuka, 
1984) . 
Molecular cloning of several cDNAs of PKC and isolaion of 
multiple PKC isozymes have established the molecular diversity of 
this enzyme family (Kikkawa et. al., 1989; Nishizuka, 1988). They 
have different degree of dependency on arachidonic acid, ca2+ and 
phosphatidylserine for their activation. PKC can also be 
activated by limited proteolysis with calpain and trypsin (Takai 
et. aI, 1977b; Inoue et. al., 1977). This hydrolytic cleavage 
results in the release of a catalytically fully active fragment, 
which will be subsequently removed from the cell. The limited 
proteolysis of the PKC molecules by calpain may be directly 
related to the initiation of degradation of the enzyme. 
The PKC isozymes I, II and III have different enzymological 
properties. Recently I some isozyme patterns of PKC have been I 
demonstrated to be Ca2 + and/or phospholipid independent (Farago f , 
I 
et. al., 1989; McFadden et. al., 1989). Moreover, different kinds :' 
of substrate of PKC may have different ca2+ dependency towards ' i 
the enzyme (Thompson et. al., 1988). 
1.3.2.3 DUAL ACTIONS OF PKC 
Under appropriate conditions it is possible to demonstrate in 
an intact cell system the independent induction of PKC activation 
and ca2+ mobilization by the exogenous application of synthetic 
DAG or PMA and a ca2+ ionophore respectively (Yamanishi et. al., 
1983). These studies revealed some interesting interactions 
16 
between the PKC and Ca 2+ pathway in a variety of cellular re-
sponses (Nishizuka, 1984). A positive feed forward action of PKC 
seems to be important in the control of gene expression (Nishizu-
ka, 1986). On the other hand, a large body of evidence has now 
accumulated to indicate that PKC provides negative feedback 
control over various steps of the cell-signalling processes such 
as decreasing the Ins(l,4,5)P3-induced elevation of intracellular 
ca2+ levels, blocking the receptor-mediated hydrolysis of inosi-
tol phospholipid, activation of the ca2+-transport ATPase and the 
Na+jCa 2+ exchange protein (Nishizuka, 1988). 
The dual actions of PKC provide a versatile regulatory system 
that is finely tuned by the transient generation of second mes- I 
sengers such as DAG. 
1.3.3 INTERACTIONS BETWEEN SECOND MESSENGER SYSTEMS 
The interactions of different receptors and second messenger I 
systems play an important role in the regulation of biological 
responses. Cross-talks exist between intracellular pathways that 
result in changes in the activity of specific effectors, such as 
ion channels in the plasma membrane, adenylate cyclase or enzymes 
of PI metabolism (Hansson, 1989). It has recently been shown that 
PKC can directly phosphorylate the adenylate cyclase catalytic 
unit (Yoshimasa et. al., 1987) and thus alter the activity of 
adenylate cyclase. Moreover, it has been reported that activation 
of PKC and subsequent stimulation of phosphodiesterase activity 
contributes to the inhibition of ~-adrenergic and forskolin 
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mediated increase in cAMP levels in intact C6 rat glioma cells 
(Bressler & Tinsely, 1990). 
1.4 SUBSTANCE PRECEPTOR ON ASTROCYTES 
1.4.1 SP AND SP RECEPTORS 
Substance P (SP) is a peptide which was first described in 
1931 (Von Euler & Gaddum, 1931) in extracts of brain and intes-
tine. The amino acid sequence of SP 
H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2, was estab-
lished in 1971 (Chang et. al., 1971). and shortly thereafter! 
synthetic SP was prepared (Tregear et. al., 1971). The availabil- I 
ity of synthetic SP has led to an exposion of interest in spi 
research. Much evidence supported that SP is a neurotransmitter 
(Nicoll, 1980; Kangawa, 1983) which can transmit information r 
I 
between cells in the nervous system. 
In 1983, two other mammalian tachykinins, namely neurokinin A ~ 
I (NKA) and neurokinin B (NKB) have been identified (Maggio et. ! 
al., 1983; Kimura et. al., 1983). The mammalian tachykinins 
(Table 1.1) (Kangawa et. al., 1983) share with the other members 
of the family such as eledoisin, physalaemin and kassinin, a 
common carboxyl-terminal sequence -Phe-X-Gly-Leu-Met-NH2, where X 
is an aromatic (Phe, Tyr) or branched aliphatic (Val, Ile) amino 





Primary structures of neurokinins 
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2 
SP, NKA and NKB are widely distributed in both the CNS and 
in peripheral tissues. These peptides evoked a variety of bio-
logical responses, including stimulation of salivary secretion, 
contraction of smooth muscle, and peripheral 
ing in a lowering of blood pressure (Pernow, 
vasodilation result-
I 
1983; Maggio, 1988; I 
Pfaff, 1988). According tO I Casta, 1988; Hokfelt, 1988; Kow & 
! 
radioligand binding and biological experiments, three distinct 
classes of tachykinin receptors in the CNS and peripheral tissues 
I 
have been identified (Lee, et. al., 1986; Quirion & Dam, 1988). 
SP receptors are coupled to the PI/PLC second 
I 
messenger I 
system in various tissues (Quirion & Dam, 1988; Diete et. al., 
1989). It has been reported that activation of NK-1 receptor in 
guinea-pig ileum, rat hypothalamus and rat salivary gland could 
stimulate phosphatidylinositol turnover (Watson and Downes, 1983; 
Hanley et. al., 1980). SP has been reported to stimulate the 
translocation of PKC in brain microvessels (Catalan, et. al., 
1989). The coupling between membrane receptors and PI-specific 
PLC has been suggested to involved a G-protein, Gp (Lo & Hughes, 
1987; Ross et. al., 1989) which is similar to the G-proteins th~t 
link receptors to adenylate cyclase (Sternweis & Pang, 1990). The 
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possibility that SP receptors are coupled to G-proteins lS sup-
ported by the observation that SP binding is modulated by guanine 
neucleotides (MacDonald & Boyd, 1989; Morishima et. al., 1989; 
Lee et. al., 1989). On the other hand, a direct adenylate cyclase 
response to the tachykinins has not yet been convincingly demon-
strated. However, SP can enhance the noradrenaline-stimulated 
cAMP level although SP by itself have no effect on the basal cAMP 
level (Rougon et. al., 1983). 
convincing evidence for the existence of specific uptak< 
mechanism for tachykinins is not yet available (Maggio, 1988). 
However, several peptidase which can cleave SP are known and some 
have been ascribed a specific role in SP fragmentation (Terenius 
& Nybergm, 1988; Lee et. al., 1981). Therefore, proteolytic 
degradation may be an inactivation mechanism for terminating SP 
action. It is interesting to note that both neuronal and astro-
blast-rich cultures from rat brain can degrade exogenously added 
SP (Horsthemke et. al., 1984). Thus, glial cells may play a I role ! 
in the regulation of the action of SP. 
1.4.2 EVIDENCE FOR THE EXISTENCE OF SP RECEPTOR IN GLIAL CELL 
Barber and coworkers (1979) have reported that SUbstance P 
like immunoreactivity (Sp+) containing fibers form extensive 
networks around blood vessels in the dorsal horn of the spinal 
cord. These networks appear to be associated with perivascular ' 
astrocytic processes rather than directly with the walls of the 
blood vessels, and synaptoid contacts occasionally occurred 
between Sp+ axon and perivascular astrocytic processes. In view 
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of the close associations and synaptoid contacts between Sp+ 
axons and astrocytic profiles throughout the neurophil of lamina 
I-Ill as well as between Sp+ axons and perivascular astrocytic 
process, they proposed that sUbstance P (SP) may be released at 
axoglia contacts. The functional effects may include: (a) an 
astrocytic channeling of relatively concentrated amount of SP 
through extracellular pathways to other targets in · the vicinity; 
(b) an astrocytic monitoring and control of extracellular levels 
of SP by active uptake and transport of the polypeptide for its 
release from other astrocytic sites, such as the perivascular 
endfeet; and (c) a SP-induced release of other neuroactive fac-
tors from the astrocytes themselves (Barber et. al., 1979). 
SP-like immunoreactivity has been demonstrated in human astro-
I 
glial cells (Michel et. al., 1979). Whether they are synthesized 
there or taken up from the neurons is currently unknown. The 
presence of SP receptors have been demonstrated in primary 
culture of astrocytes from neonatal mouse cerebral cortex (Tor-
rens et. al., 1986), human astrocytoma (Lee et. ale, 1989) and 
rat glioma cells (Perrone et. al., 1986). The pharmacology of the 
SP binding sites on human astrocytoma cells suggests they belong 
to the NK-1 tachykinin receptor subtype .(Lee et. al., 1989). 
Activation of SP receptors on the mouse cortical astrocytes has 
been reported to stimulate the turnover of phosphatidylinositol 
(Torrens et. al., 1989). Moreover, activation of NK-1 receptor by 
SP can stimulate uridine incorporation in human astrocytoma cells 
(Lee et. al., 1989) indicating that it is a functional recepto~. 
Perrone and coworkers (1986) have also demonstrated the presence 
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of SP receptor on LRM 55 glioma cells. Its activation can inhibit 
the isoproterenol-stimulated taurine release. These observations 
prompted the present study to examine the effect of SP on the 
release of taurine from human astrocytoma (U-373 MG) cells and 





CHAPTER TWO. METHODS 
2.1 IN VITRO CULTURE OF HUMAN ASTROCYTOMA CELLS (U-373 MG) 
2.1.1 PREPARATION OF REAGENTS 
(1) Minimum essential medium (MEM) 
MEM with Eagle's salt and L-glutamine (MEM) was pruchased 
from Gibco Lab. (Grand Isand , N.Y., U.S.A.). Each package of MEM 
was made up to one litre in double distilled water. 2.2 g of 
sodium bicarbonate was added and the pH was then adjusted to 7.2 
with Hel. The solution was sterilized by passing through a 
millipore filter (0.2 ~m, Schleicher & Schwell membrane filter) 
under suction and then stored at 4 oC. 
(2) Phosphate buffered saline (PBS) 
PBS was prepared by dissolving 8.18 g NaCI, 0.2 g KCI, 1.44 g 
Na 2HP04 .12H20 and 0.2 g KH 2P04 in one litre double distilled 
water. The pH was then adjusted to 7.2 with Hel and made sterile 
by autoclaving at 1210 C for 30 min. 
(3) Trypsin (0.1%) in PBS 
One hundred mg trypsin (from bovine pancreas, Type Ill, 10200 
units/mg) (Sigrna) were dissolved in 100 ml PBS (pH 7.2). The 
trypsin solution was made sterile by passing through a millipore 
filter (0.2 ~M) under suction. The trypsin solution was stored in 
10 ml aliquot at -20°C. 
(4) Complete minimum essential medium (CMEM) 
Fifty ml horse serum (GIBCO), 10 ml MEM amino acid solution 
(50X) (without L-glutamine) (GIBCO), 10 ml MEM vitamin solution 
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(100X) (GIBCO), 10 ml penicillin (10,000 units/ml) and streptomy-
cin (10,000 Mg/ml) solution (GIBCO) and 2.5 ml 100 mM L-glutamine 
(GIBCO) were added to 422.5 ml sterilized MEM. Hence, CMEM con-
tained double concentration of all amino acids except L-glutamine 
(2.8 mM), a quadruple concentration of MEM vitamin solution, 10% 
(v/v) horse serum, 200 IU/ml of penicillin and 200 Mg/ml of 
streptomycin. 
2.1.2 CULTURE OF ASTROCYTOMA CELLS 
Human astrocytoma cells (U-373 MG) were obtained from 
American Tissue culture Association (Rockville, MD, D.S.A.). 
It is an adherent cell line and grows in monolayer. They were ' 
cultured at 37 0 C in a humidified incubator under 5% CO2/95% air 
in CMEM and were grown in 75 cm2 tissue culture flask (Falcon, I 
Becton Dickinson & Company). 
Cells were subcultured once per week and the medium was 
changed 4 days later. To change medium, the old medium was re-
moved and 15 ml fresh medium prewarmed to 37 0 C was added to the 
culture flask and then the culture was returned to the incubator. 
To subculture the cells, the old medium was discarded and the 
cells rinsed with 10 ml of sterilized PBS. This step was designed 
to remove most of the remaining serum which would inhibit the 
action of trypsin. One ml of 0.1% trypsin in PBS was added to 
cover the monolayer completely. The flask was shaked occasionally 
until the cells detached. Then, 10 ml of CMEM was added and the 
cell suspension was centrifuged in a sterilized centrifuge tube 
at 110 9 for 5 min. The supernatant was discarded and the cell 
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pellet was re suspended in 10 ml of CMEM. The cells were dispersed 
by pipetting the mixture up and down gently. Cells were counted 
and the mixture diluted to a plating density of 1 x 10 4 cells/cm2 
on 75 cm2 culture flasks. The flask was capped and returned to 
the incubator. 
2.1.3 CELL PLATING IN 24-WELL PLASTIC TRAYS 
The cells were harvested after trypsin digestion as described 
above. After centrifugation and resuspension in 10 ml of CMEM, 
cells were counted on a hemocytometer. One hundred Ml of the cell 
suspension were added to 100 Ml of a trypan blue solution [0.1 g 
trypan blue (Sigma) dissolved in 50 ml PBS] and then applied to 
the hemocytometer. Since dead cells were stained blue in the 
trypan blue solution, they could be differentiated from the 
viable ones (Philip, 1973). The number of viable cells (y) was 
counted. The viable cell ·concentration of the original cell 
suspension could then be calculated by the following equation: 
Total number of viable cells 
= y x 2 (dilution factor) x 10 (original cell volume) XI0 4 
The cell suspension was diluted to 2-4 x 105 cells/ml by 
adding the appropriate volume of CMEM. One ml of the cell suspen-
sion was added to each well of a 24-well flat bottomed plastic 
tray (Nunclon). The 24-well plates were put into the incubator 
and cultured for 24 to 48 h before experiment. 
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2.2 DETERMINATION OF [3H]-TAURINE RELEASE 
2.2.1 PHYSIOLOGICAL SALT SOLUTION (PSS) 
PSS was prepared freshly on the day of experiment. The 
buffer had the following composition: 118 mM NaCl, 1.2 mM KH2P04 , 
4.7 mM KCl, 1.2 mM MgS0 4 , 3 mM CaC1 2 , 20 mM glucose, 20 mM HEPES 
and 0.05% bovine serum albumin (BSA). It was adjusted to pH 7.2 
with HCl and then kept in a 37 0 C water bath. 
2.2.2 PREPARATION OF WORKING [3H]-TAURINE SOLUTION 
[3HJ-taurine (specific activity: 35 Ci/mmol, Amersham) was 
diluted with PSS to give a 20-30 nM solution. This solution was 
freshly prepared before each experiment. 
2.2.3 ASSAY OF [3H]-TAURINE RELEASE 
The protocol was similar to that employed by Perrone and co-
workers (1986) with some modifications. 
For release experiments, cells were plated at a plating 
density of 2-4 x 105 cells/well on a 24-well plastic tray and 
cultured at 37 0 C for 24-48 h. To load up cells with [3HJ-taurine, 
cells were washed twice (2 x 2 ml) with PSS before adding 0.4 ml 
of a working solution of [3HJ-taurine (20 - 30 nM) to each well. 
The plate was then returned to the incubator and incubated for 60 
min or for an indicated period of time for time course studies. 
After incubation, cells were washed twice with PSS to remove the 
extracellular [3HJ-taurine. Fresh aliquots (0.5 ml) of PSS, pre-
warmed to 37 0 C was added to each well and the supernatant was 
removed and replaced with fresh medium after 5 min incubation at 
37 oC. This step was repeated every 5 min for 40 min. Initial 
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experiments indicated that a 40 min wash out period allowed 
[3HJ-taurine release to approach its steady state (Fig. 3.1). 
Cells were then incubated at 37 0 C for 15 min (or for an indicated 
period of time for time course experiments) in the presence or 
absence of various tested drugs. After incubation, the superna-
tant was removed and saved. Cells in each well were scrapped off 
in 0.5 ml 100 mM EDTA.2Na and transferred to a counting vial. The 
amount of [3HJ-taurine in the supernatant and in the cells were 
determined by liquid scintillation counting in a home-made scin-
tillation fluid (0.4 g POPOP, 4 g PPO, in 1 liter mixture of 666 
ml toluene and 333 ml Triton X-lOO) . 
2.2.4 DRUG PRETREATMENT 
To test the effects of spantide (a SP antagonist) and stau-
rosporine (a PKC inhibitor) after a 40 min wash out period 
cells were preincubated with the drug for an indicated period of 
time prior to the addition of SP or PMA. 
2.2.5 DATA ANALYSIS 
Results are presented as percentage of fractional release or 
percentage of basal release. 
Percentage of [3HJ-tau in med. (cpm)xlOO% 
fractional release = 
([3HJ-tau in med. + [3HJ-tau in cell) (cpm) 
% of basal release = 
% of fractional release 
in the presence of drug 
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Figure 2.1 
The time course of [3HJ-taurine release from human astrocytoma 
cell s (U-373 MG). Cell s were stimula ted by buffer and the 
supernatant were removed and replaced with fresh buffer every 3 
min for 45 min. Cells were then exposed to SP or buffer for 3 
min and then the supernatant were removed and replaced with fresh 
buffer. The arrow indicates the addition of SP (100 nM) 
( • ) or buf fer ( 0 ). 
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2.3 DOWN REGULATION OF PKC ACTIVITY BY PROLONGED ·PMA PRETREATMENT 
2.3.1 PREPARATION OF WORKING PHORBOL-12-MYRISTATE-13-ACETATE 
(PMA) SOLUTION 
(a) PMA (Sigma) was dissolved in DMSO (Merck) to give a stock 
concentration of 10 mM and stored at - 20 oC. 
(b) The stock solution was diluted with CMEM to give a final 
concentration of 10 ~M. PMA solution was made sterile by passing it 
through a millipore filter (0.2 ~m) under suction. 
2.3.2 PRETREAMENT OF CELLS WITH PMA 
Cells either cultured in 24-well plates for 24 h or grown to 
confluence in 75 cm2 culture flask were employed for chronic 
treatment with PMA. One day before the experiment, the growth 
medium was removed and 0.5 ml of sterilized PMA working solution 
(10 ~M) .was added to each well of the 24-well plate (or 10 ml 
PMA solution in 75 cm2 culture flask) and the cells were returned 
to the incubator. Release experiments and PKC measurements were 
made after cells had been pretreated with 10 ~M PMA for 19 h. 
2.4 DETERMINATION OF cAMP 
The assay was based on the principle of radioimmunoassay. A 
fixed amount * of radiolabelled cAMP (cAMP ) was competed with 
nonradioactive cAMP for limited amount of cAMP binding protein. 
Where higher amount of nonradioactive cAMP was present in the 
sample, less cAMP* will bind to the binding protein. The separa-
29 
tion of binding protein-cAMP* complex from free cAMP* was per-
formed by the adsorption of free cAMP* on activated charcoal. 
2.4.1 DRUG EFFECTS ON cAMP 
C~lls were plated in 24-well plates and cultured in an incu-
bator at 37 0 C for 24-48 h. To begin experiment, cells were washed 
twice with PSS · (2 x 2 ml) and then preincubated in 350 ~l PSS in 
an incubator. After 30 min preincubation, 100 ~l 4.5 mM isobutyl 
methylxanthine (IBMX) was added to give a final concentration of 
1 mM. After 10 min incubation, the IBMX containing PSS solution 
was removed and the cells were incubated with various tested drug 
solutions containing 1 mM IBMX in a 37 0 C water bath for 10 min 
in a final volume of o.s ml. To terminate the reaction, the 
medium was removed and 0.5 ml of a 7.5% ice-cold trichlorocetic 
acid (TCA) was added and put on ice for 15 min. The mixture was 
collected and centrifuged at 2000 rpm for 5 min to remove the 
precipitate. The TCA in the supernatant was removed by diethyl 
ether extraction (4 x 2 ml) and then residual traces of ether 
was blown off. The level of cAMP in the aqueous phase was deter-
minated immediately using a cAMP assay kit from Amersham. 
2.4.2 DATA ANALYSIS 
The specific binding of [3HJ-CAMP was obtained by sUbstract-
ing · the value of blank (in the absence of cAMP binding protein). 
The specific binding in the absence of unlabeled cAMP (i.e. 
standard zero) was designated as Co while the specific binding in \ 
the presence of unlabeled cAMP from standard or sample was desig-
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nated as CX. The ratio of Co/Cx was calculated from each tube. A 
linear calibration curve was obtained by plotting Co/Cx against 
picomoles of standard cAMP. The amount of cAMP in the sample was 
then read off from the graph using their co/cx values. A typical 
calibration curve for cAMP determination is shown in Fig. 2.2. 
2.5 MEASUREMENT OF INOSITOL PHOSPHATES 
2.5.1 DOWEX COLUMN PREPARATION 
Inositol phosphates were separated by anion-exchange chroma-
tography using Dowex columns. Dowex resin (Bio-rad AG 1-X8, 
formate form, 200-400 mesh) was washed with five bed volume of 
distilled water. The washed resin was resuspended in an equal 
volume of distilled water. Approximately 1.5 ml of the Dowex 
suspension was added to a column (1 x 5 cm, Bio-rad) in order to 
give a resin bed of 1.5 cm in height. The column was washed 
twice with 5 ml distilled water and ready for sample loading. 
2.5.2 DETERMINATION OF TOTAL INOSITOL PHOSPHATES 
Cells were cultured on 24-well plastic plates as described 
previously. Polyphosphoinositide hydrolysis at 37 0 C induced by 
substance P was monitored by measuring [3HJ-inositol phosphates 
(IPs) accumulation with some modifications of the procedure 
described by Downes and coworkers (1986). 
Briefly, phosphoinositides were labelled by incubating cells 
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Figure 2.2 
A typical standard curve for cAMP determination. The specific 
binding in the absence of unlabeled cAMP was designated as Co 
while the specific binding in the presence of unlabeled cAMP from 
standard was designated as ex. 
32 
' . 
specific activity: 10-20 Ci/mmol) in CMEM. The extracellular 
[3HJ-inositol was then washed away and cells were equilibrated in 
PSS for 30 min. To amplify the PI hydrolysis signal, cells were 
then preincubated in 0.5 ml PSS containing 10 mM Liel for 15 min. 
Various tested drugs in PSS containing 10 mM Licl were then added 
and cells were incubated for 30 min. Reaction was terminated by 
discarding the medium and adding 1 ml of ice-cold 5% perchloric 
acid (HCI0 4 ). Cells were kept on ice for 15 min. The supernatant 
was then transferred to a glass test tube. To extract the per-
chloric acid, 1 ml mixture of Tri-n-octylamine (Sigma) and tri-
chlorotrifluoroethane (Sigma) (1:1, v/v) was added, followed by 
100 ~l of 100 mM EDTA. The mixture was vortexed vigorously and 
then centrifuged at 2000 rpm for 1 min at room temperature. The 
upper aqueous layer was collected and diluted to 5 ml with dis-
tilled water. 
2.5.3 COLUMN SEPARATION 
The sample was adjusted to pH 7.0 with 50 mM NaOH and then 
applied to a Dowex (AG 1-X8) column. To remove free [3HJ-inosi-
tol, the column was washed with 2 x 5 ml of distilled water. 
Glycerol-phosphoinositol was eluted by adding 2 x 5 ml of 60 mM 
sodium formate/5 mM sodium tetrabrate. Total [3HJ-inositol phos-
phate were eluted by adding 5 ml of 1 M ammonium formate/100mM 
formic acid. Radioactivity in the fractions was determined by 
liquid scintillation spectrometry. 
The column was regenerated by adding 10 ml of 2 M ammonium 
formate/lOO mM formic acid and then washed with 10 ml of dis- '. 
tilled water. 
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2.5.4 DETERMINATION OF INOSITOL TRISPHOSPHATE (IP3 ) 
The IP3 level was measured according to the procedure of 
Downes and coworkers (1986). 
To measure [3 H]-IP3 accumulation, cells were labeled with 8 
~Ci/ml of [3H]-inositol for 17-20 h. Cells were washed and pre-e 
quilibrated in PSS (without LiCI) for 30 min. Various tested 
drugs were then added in a final incubation volume of 0.5 ml and 
cells were incubated for 15 s. Reaction was terminated by adding 
0.5 ml ice-cold 10% TCA . TCA was extracted as described previ-
ously (section 2.4.1). The samples were diluted to 5 ml with 
distilled water and adjusted to pH 7.0 with NaOH. The samples 
were then applied to Dowex anion-exchange columns. [3H]-inositol 
was eluted with 2 x 5 ml of water. Glycerol-phosphoinositol was 
eluted with 2 x 5 ml of 60 mM sodium formate/ 5 mM sodium tetrab-
orate. [3H] -inositol monophosphate was eluted with 2 x 5 ml of 
150 mM ammonium formate/lOO mM formic acid. [3HJ-inositol bis-
phosphate was eluted with 2 x 5 ml of 0.4 M ammonium formate/lOO 
mM formic acid. [3H]-inositol trisphosphate was eluted with 2 x 5 
ml of 0.8 M ammonium formate/lOO mM formic acid. Radioactivity in 
the fractions was determined by liquid scintillation spectrome-
try. 
2.6 MEASUREMENT OF PKC 
2.6.1. PREPARATION OF CYTOSOLIC AND MEMBRANE BOUND PKC 
2.6.1.1. REAGENT PREPARATION 
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(1) 100 mM EDTA.2Na 
1.9 g EDTA.2Na (Sigma) was dissolved in 40 ml of 50 mM Tris-
HCl (pH 7.4) and its pH was adjusted to 7.4 with 1 M NaOH. The 
final volume was adjusted to 50 ml with Tris-HCl (pH 7.4). 
(2) 100 mM EGTA 
1.86 g EGTA (Sigma) was dissolved in 40 ml of 50mM Tris-HCl 
(pH 7.4) and its pH was adjusted to 7.4 with 1 M NaOH. The final 
volume was adjusted to 50 ml with Tris-HCl (pH 7.4). 
(3) Solution A 
Solution A contained 20 mM Tris-HCl (pH 7.4), 2 mM EDTA, 2mM 
EGTA, 5mM dithiothreitol (Sigma), 2 mM phenylmethylsulfonyl 
fluoride (PMSF, Sigma). It was made -up of 40 ml of 50 mM Tris-HCl 
(pH7.4), 2 ml of 100 mM EDTA.2Na, 2 rnl of 100 mM EGTA, 77 mg of 
dithiothreitol, 34.5 mg of PMSF and 56 ml of distilled water. It 
was mixed for 10 h until all ingredients were completely dis-
solved and then stored at 4 °c before used. 
(4) Solution B 
Solution B was consisted of solution A plus 0.1 mM leupeptin 
(Sigma). It was freshly prepared before each experiment. 
(5) Solution C 
Solution C was made up of solution B plus 1% Triton X-lOO. 
2.6.1.2. PREPARATION OF DEAE-CELLULOSE COLUMN 
(1) 5 grams of DEAE-cellulose (Sigma) was re suspended five times 
in 5 X 300 rnl of distilled H20 to remove the fines. 
(2) 300 ml of 0.5 M HCl was added to the washed DEAE-cellulose 
35 
and mixed occasionally for half an hour. 
(3) The mixture was transferred to a column and washed with 
distilled H20 until the pH of eluent was larger 4. 
(4) The DEAE-cellulose was returned to a beaker and 300 ml of 
0.5 M NaOH was added and mixed occasionally for half an hour. 
(5) The mixture was transferred to a column and washed with 
distilled H20 until the pH of the eluent was about 7. 
(6) The DEAE-cellulose was returned to a beaker and resuspended 
in 250 ml of 50 mM Tris-HCI (pH 7.4). It was stored at 40 C before 
use. 
(7) For PKC separation, approximately 10 ml of the DEAE-cellulose 
suspension was added to a column (0.8 x 10 cm, Bio-rad) to give a 
2 cm DEAE-cellulose column. 
(8) The column was ready for use after washed once with 5 ml 
solution A (4 oC). 
2.6.1.3. PROTOCOL OF PREPARING CYTOSOLIC AND MEMBRANE BOUND PKC 
The activity of PKC was assayed according to the procedure of 
XU and coworkers (1989). 
Astrocytoma cells were cultured to confluence in a 75 cm2 
Falcon flask as previously described. To study the effects of 
drugs on PKC activity, cells were pre-equilibrated in MEM with-
out horse serum for 30 min. They were then incubated with SP or 
MEM for indicated periods of time. After inCUbation, cells were 
washed three times with ice cold PBS. They were then scaped off 
and centrifuged at 110 g for 5 min. The supernatant was discarded 
and the pellet was homogenized in 3 ml of ice cold solution B 
with glass pestle. The homogenate was centrifuged at 100,000 g 
for 1 h at 4 °C. The supernatant was saved and represented the 
cytosolic fraction. The pellet was resuspended in solution C and 
incubated for 1 h at 4oC. The mixture was centrifuged at 100,000 
g for 1 h at 4 °c to obtain the soluble membrane fraction. Both 
cytosolic and soluble membrane fractions were applied to DEAE-
cellulose columns which were pre-equilibrated in solution A. 
After the samples were applied, the columns were washed with 10 
ml of ice-cold solution A and PKC activity was eluted with 1.5 ml 
of solution B containing 50 mM NaCl. An aliquot (15 Ml) of the 
eluate was used to determine its PKC activity. 
2.6.2. PKC ASSAY 
2.6.2.1. REAGENT PREPARATION 
(1) CaC1 2 (20 mM) 
29.4 mg CaC1 2 was dissolved in 10 ml 50 mM Tris-HCl (pH 7.4) 
and stored at 4 °C. 
(2) Phosphatidylserine (PS) (200 ~gjml) 
200 ~l of PS (Sigma) was taken out from stock solution (1 
mgjml) and the solvent (chloroform j methanol) was removed by 
a stream of nitrogen gas. One ml of 50 mM Tris-HCl (pH 7.4) 
was added and the mixture was sonicated in an ice bath with 
an ultrasonicator (Cole-Parmer model 883) for 30 seconds until 
a clear solution was obtained. The PS solution was stored at 
40 C and used within the same day of preparation. 
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(3) Histone III-S (8 mg/ml) 
Eight mg of histone III-S (Sigma) was dissolved In 1 ml of 50 
mM Tris-HCl (pH 7.4) and stored at 4oC. 
(4) MgCl 2 (40 mM) 
813.2 mg MgCl 2 was dissolved in 100 ml of 50 mM Tris-HCl 
(pH 7.4) and stored at 4oC. 
(5) Working solution of gamma-[32PJ-ATP (0.3 ~M) 
( specific activity: 3000 Ci/mmol, Amersham) was diluted with 
50 mM Tris-HCl (pH 7.4) to give a 0.1 mCi/ml solution. 
This solution was freshly prepared before each experiment. 
(6) PKC reagent mixtures 
4 different PKC reagent mixtures were prepared as follows: 
Volume of reagent ( ~l ) 
Reagent mixture 1 2 3 4 
40 mM MgCl 2 125 125 125 125 20 mM caCl 2 50 50 200 ~g/ml PS 50 50 
8 mg/ml histone III-S 25 25 25 25 
50 mM Tris-HCl (pH7.4) 100 50 50 
2.6.2.2. PKC ACTIVITY ASSAY PROTOCOL 
An aliquot (15 ~l) of the cytosolic and soluble membrane PKC 
preparation eluted from DEAE-cellulose column was pre-incubated 
with each of 4 different reagent mixtures for 5 min at 30oC. The 
reaction was initiated by adding 10 ~l of the working solution of 
gamma-[32PJ-ATP solution to give a final reaction volume ·of 50 ·· 
~l. The reaction was terminated after 20 min by adding 1 ml of 
ice-cold 10% TCA. The mixture was filtered through GF IC glass 
fibre filters under reduced pressure. The radioactivity on the 
filters was determined by liquid scintillation spectrometry. 
2.7. STATISTICAL METHOD 
All results were expressed as the arithmatic mean ± standard 
deviation. The significance of difference between control and 





CHAPTER THREE. RESULTS 
3.1 SOME CHARACTERISTICS OF TAURINE TRANSPORT IN U-373 MG ASTRO-
CYTOMA CELLS 
3.1.1 TIME AND SODIUM DEPENDENCE OF TAURINE UPTAKE 
When the U373 MG cells were incubated at 37 0 C with 20-30 nM 
[3 HJ - taurine, they accumulated [3HJ-taurine in a time depend-
ent manner. After 1 h incubation, about 70% of the extracellular 
(3 H] -taurine were found in the cells (Table 3.1). Preliminary 
experiments indicated that SP (100 nM) can induce the release of 
(3 H] -taurine from preloaded cells and the magnitude of the re-
lease in terms of percent of basal release was similar in cells 
prelabelled with [3 H]-taurine for 15 to 120 min (Table 3.1). For 
convenience and good signal, one hour preincubation with [3 H]-
taurine was chosen in all subsequent experiments. 
Similar to that reported for glioma cells and primary culture 
of astrocytes (Yuasa & Hamprecht, 1987) 1 the uptake of [3H]-
taurine by U-373 MG astrocytoma cells was sodium-dependent. When 
\ 
sodium chloride in PSS was replaced by an equal molar concentra-
tion of choline chloride (PSS-choline chloride), only 2.3% of the 
extracellular [3HJ-taurine were taken up into the cells after 1 h 
incubation. However 1 when the cells were incubated with (3 H]-
taurine in normal PSS (PSS containing 118 mM NaCl) , 82% of extra-




Time course of [3HJ-taurine uptake and i 1s effect on basal and 100 nM SP-induced release of [ HJ-taurine 
Incubation ~ 0 of 
time [3HJ-tau 
(min) Uptake 
15 22.3 ± 0.4 
30 47.4 ± 1.0 
60 67.5 ± 1.8 
120 78.4 ± 1.5 
% of fractional release stimulation by 
100 nM SP 
Buffer 
1.12 ± 0.10 
0.87 + 0.15 
1.01 ± 0.15 
0.88 ± 0.15 













4'03 ± 30 
490 ± 22 
404 ± 18 
454 ± 60 
Cells were preincubated with [3HJ-taurine for the indicated time 
and then the release of [3 HJ -taurine induced by 100· nM , SP was 
assayed as described in method (Section 2.2). Values ' presented 
are the means ± S.D. of triplicate determinations. Both basal 
release and 100 nM SP-induced [3HJ-taurine release are not 
significantly different at the 4 different incubation time when 
compared by Student's t-test. Similar results were obtained in 
two separate experiments. 
Table 3.2 




% of [3 HJ taurine uptake 
81.7 ± 2.0 
2.4 ± 0.0 
Cells were incubated with [3HJ-taurine in normal PSS or "PSS-
choline chloride" for 1 h and then washed and collected for 
scintillation counting as described in method (section 2.2) .In 
"PSS-choline chloride" medium, the NaCl was replaced by equal 
molar concentration of choline chloride. Data shown are the means 
± S.D. of triplicate determinations. Similar results were ob-
tained in two separate experiments. 
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3.1.2 TIME DEPENDENCE OF SP-STIMULATED TAURINE RELEASE 
The release of [3HJ-taurine induced by SP (100 nM) is a time 
dependent phenomenon. Maximal response was obtained after 15 min 
incubation and longer incubation resulted in a decrease of SP 
response (Figure 3.1). Thus, a 15 min incubation time was chosen 
in all subsequent experiments. 
3.1.3 EFFECT OF IONS ON SP-STIMULATED TAURINE RELEASE 
3.1.3.1 EFFECT OF SODIUM ON TAURINE RELEASE 
In contrast to [3 HJ -taurine uptake, SP-induced taurine re-
lease was largely sodium independent. When the cells were prein-
cubated with [3HJ-taurine in normal PSS and then transferred to a 
PSS-choline chloride medium with or without 100 nM SP, SP stimu-
lated release by 4.1 and 3.4 fold over basal in the presence and 
in the absence of sodium chloride, respectively (Table 3.3). 
Even when cells were preincubated wi th [3 HJ -taurine in a 
PSS-choline chloride medium, 100 nM SP was able to give 2.8 fold 
stimulation over basal release (Table 3.3). 
It should be noted that the basal release of [3HJ-taurine was 
affected by sodium. Higher [3HJ-taurine release was observed as 
sodium chloride was gradually replaced by choline chloride 
(Figure 3.2). 
3.1.3.2 EFFECT OF POTASSIUM ON TAURINE RELEASE 
It has been demonstrated that high K+ concentration (10-8~ 
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Figure 3.1 
Time course of the basal ( 0 ) and SP-induced [3HJ-taurine re-
lease ( • ) from U-373 MG astrocytoma cells. Data given are the 
means ± S.D. of triplicate determinations. Similar results were 
obtained in 4 separate experiments. 
Table 3.3 





in normal PSS 





for 1 h 
% of fractional release 
Normal PSS PSS-choline choride 
Buffer 100 nM SP Buffer 100 nM SP 
0.64 ± 0.10 2.60 ± 0.11* 2.20 ± 0-.50 - 7.54 ± 0.66* 
2.21 ± 0.44 6.11 ± 0.16* 
There ar~ significant difference between buffer and 100 nM SP-
induced [ HJ-taurine release. *,p<0.05 (Student1s t-test). Values 
presented are the means ± S.D. of triplicate determinations. 
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Figure 3.2 
Effect of replacing sodium chloride by chloine chloride on the 
release of [3HJ-taurine from U373 MG astrocytoma cells. To exam-
ine the Na+-dependence of taurine release, equal molar concentra-
tion of NaCl in PSS was replaced by the indicated molar concen-
tration of choline chloride. Data shown are the means ± S.D. of 
triplicate determinations. 
cytes (Philiber et. al., 1988). Therefore, the effect of high K+ 
concentration (40 mM) on basal and 100 nM SP-induced [3 H]-taurine 
release was examined. The result indicated that adding 40 mM KCI 
in PSS containing 118 mM NaCI had little or no effect on the 
basal release but greatly reduced the release of taurine induced 
by 100 nM SP (Table 3.4). 
To examine whether this can be accounted for by the hyper-
osmotic effect of KCI, the effect of an equal molar concentra-
tion of surcose was studied. Both basal and 100 nM SP-stimulated 
release of [3HJ-taurine were decreased in the presence of sucrose 
(Table 3.4). However, when 40 mM KCl was added to PSS contain-
ing 82.7 mM NaCl (to maintain iso-osmolarity as normal PSS), only 
the SP induced release was inhibited (Table 3.4). Therefore, the 
inhibitory effect of high potassium concentration on SP stimulat- I 
ed release of [3H]-taurine was not a simple result of hyperosmot-
ic effect. 
3.1.3.3 EFFECTS OF CALCIUM AND MAGNESIUM ON TAURINE RELEASE 
A lowering of the extracellular calcium chloride level from 3 
mM to 0.1 mM or the complete removal of extracellular ca2+ did 
not affect the basal release of [3 H]-taurine but decreased the 
100 nM SP stimulated release slightly (Table 3.5). 
The presence of a high concentration of MgCl 2 (10 mM) in PSS 
containing normal (3 mM) or lower (0. 1 mM) level of CaC1 2 de-
creased both the basal and 100 nM SP-stimulated [3 H] -taurine 
release. The net stimulation of [3 HJ -taurine release by 100 nM SJ' 





Effect of K+ on [3HJ-taurine release 
from U-373 MG astrocytoma cells 
% of fractional release stimulation by 
100 nM SP 
Buffer 100 nM SP (% of basal release) 
control PSS 
(118 mM NaCl, 
4.7 mM KCl) 
PSS (118 mM NaCl, 
40 mM KCl) 
0.49 ± 0.01 1.56 ± 0.1 
0.47 + 0.05 0.67 ± 0.07** 
PSS ( 118 mM NaCl, 0.29 ± 0.03*0.37 ± 0.07** 
80 mM surcose) 
PSS (82.7 mM NaCl, 
40 mM KCl) 
0.49 ± 0.05 0.83 ± 0.06** 
318 ± 20 
143 ± 15 ** 
128 ± 24 ** 
169 ± 12 ** 
Cells were incubated in buffers containing different concentra-
tions of NaCl and KCl as indicated in the table with or without 
100 nM SP. Values presented are the means ± s.o. of triplicate ' 
determinations. The SP induced release are significantly lower 
in all tested medium when compare with that in control-PSS 
(*,p<0.05 ; **,p<O.Ol) using student's t-test. Similar results i 




Effect of Ca2+ & Mg 2+ on [3HJ-taurine release 




(3 mM caC1 2 , 1.2 mM MgS04 ) 
PSS 
(0.1 mM CaC1 2 , 1. 2 mM Mgs04 ) 
PSS 
(No CaC1 2 , 1.2 mM MgS0 4 ) 
PSS 
(No CaC1 2 , 
1 mM EGTA, 
1.2 mM MgS04 ) 
PSS 
(0.1 mM caC1 2 , 10 mM MgS0 4 ) 
PSS 
(3 mM caC1 2 , 10 mM MgS04 ) 
% of fractional release 
Buffer 100 nM SP 
0.54 ± 0.03 2.25 ± 0.1 
0.52 ± 0.01 2.44 + 0.09 
0.49 + 0.02 2.00 ± 0.07 
0.57 ± 0.02 1.98 ± 0.03 
0.36 ± 0.10 1.62 ± 0.23 
stimulation by 
100 nM SP 
(% of basal release) 
417 ± 20 
469 ± 17 
408 ± 14 
347 ± 5 * 
450 ± 64 
0.27 + 0.03**1.28 + 0.08** 475 ± 30 
Cells were incubated in PSS buffer containing the indicated 
concentrations of CaC1 2 and MgS04 with or without 100 nM SP. Data given are the means ± S.D. of triplicate determinations. 
*,p<0.05, **,p<0.02 when compared with control PSS using stu-
dent's t-test. Similar results were obtained in two separate 
experiments. 
~, . 
from that of the control PSS medium (Table 3.5). 
3.~.4 TEMPERATURE-DEPENDENCE OF [3 H]-TAURINE RELEASE 
Lowering the incubation temperature from 37 0 C to 4 0 C inhibit-
ed both the basal and 100 nM SP-induced [3 H] -taurine release 
(Table 3.6). The release induced by 100 nM SP was inhibited to a 
much greater extent. 
3.~.5 COMPARISON OF CHEMICAL-INDUCED RELEASE OF TAURINE AND GABA 
FROM U-373 MG ASTROCYTOMA CELLS 
After incubating the cells with [3 H]-taurine (20 nM) for 1 h, 
about 70% of the extracellular [3HJ-taurine was taken up into the 
cells. In contrast, only about 10% of the extracellular [3HJ-GABA 
was taken up after incubating the cells with [3 H ]-GABA (7 nM) 
under identical conditions. In addition, the fractional release 
of [3 H]-taurine was about 0.5-1.0% while that of [3 H]-GABA was 
about 15%, indicating a much higher basal release of [3HJ-GABA. 
While SF, IPR and PMA were all found to stimulate significant- I 
ly the release of [3 H]-taurine, only SF was found to enhance 
slightly the release of [3 H ]-GABA (20 % over basal release) 
(Table 3.7). 
3.2 PHARMACOLOGICAL STUDIES OF SP-STIMULATED TAURINE RELEASE 
3.2.1 EFFECT OF MAMMALIAN TACHYKININS AND THEIR ANALOGUES ON THE 
RELEASE OF [3H]-TAURINE 
SP stimulated the release of [3 H]-taurine in a 
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Table 3.6 
Effect of temperature on [3HJ-taurine release 
from U-373 MG astrocytoma cells 
% of fractional release stimulation by 
100 nM SP 
Temperature (oC) Buffer 100 nM SP (% of basal release 
37 
4 
0.59 ± 0.05 2.62 ± 0.08 
0.41 ± 0.02* 0.60 ± 0.08** 
444 ± 14 
146 ± 20** 
Cells were incubated in PSS at 37°C or 40 C with or without 100 nM 
SP. Values presented are the means ± S.D. of triplicate determi-
nations. There are significant difference between both buffer & 
100 nM SP response at 37°C & 4°C *,p<0.05 **,p<O.Ol when tested 
by student's t-test. 
Table 3.7 
Comparison of sUbstance P (SP), isoproterenol (IPR) and phorbol- ' 
12-myristate-13-acetate (PMA)-induced [3 H]-GABA and [3 H]-taurine 
release from U-373 MG astrocytoma cells 
~ 0 of fractional release 
[3HJ-taurine [3HJ-GABA 
Control 0.57 ± 0.04 13.68 ± 0.59 
100 nM SP 2.4 ± 0.19 
* 
16.45 ± 0.23** 
100 nM IPR 1.21 ± 0.16 
* 
14.97 ± 0.41 
1 J.LM PMA 2.78 ± 0.05 * 15.88 ± 0.39 
Cells were preincubated in PSS at 37°C with [3 H]-taurine (20 nM)' 
or [3 H]-GABA (7 nM ) for 1 h and then drug induced [3HJ-GABA and 
[3HJ-taurine release were assayed as described in method. *,p< 
0.02; **,p<0.05 when compared with control using student's t-
test. Results are the means ± S.D. of triplicate determinations. 
Similar results were obtained in two separate experiments. 
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concentration-dependent manner (Figure 3.3). The ECSO (concentra-
tion of drug which produces the half maximal response) of SP was 
0.31 ± 0.06 nM (mean ± S.D. ; n=6). At 100 nM, SP produced a 3-
to S-fold increase in the [3HJ-taurine release. 
Two other mammalian tachykinins, NKA and NKB, were also able 
to stimulate [3 H]-taurine release and displayed an EC50 of 20 nM 
and 200 nM, respectively (Table 3.8). Moreover, two synthetic SP 
hexapeptide analogues, [Glp6, D-pro 9 J-SP(6-11) and [Glp6, 
L-pro9 ]-SP(6-11), were found to stimulate [3HJ-taurine release 
with an EC50 of 3.6 ~M and 20 nM respectively. Therefore the rank 
order of potencies of tachykinins in stimulating the release of 
[3 HJ -taurine from astrocytoma cells vras SP » NKA » NKB and 
[Glp6, L-pro9 J-SP(6-11) was about 180 times more active than 
[Glp 6, D-pro9 J-SP(6-11). 
3.2.2 ANTAGONISTIC EFFECT OF SPANTIDE ON SP-STIMULATED [3H]_ 
TAURINE RELEASE 
In order to define whether the pharmacological effect of SP 
on taurine release is a receptor mediated event or not, the 
effect of a SP receptor antagonist, spantide, was studied. Span-
tide, at 1 ~M and 10 ~M, concentration-dependently shifted the 
concentration-response curve of SP to the right (Figure 3.4). The 
inhibitory effect of 10 ~M spantide was more prominent than that 
of 1 ~M. Spantide (1-10 ~M) had little or no effect by itself 





stimulation of [3 H]-taurine release in human astrocytoma (U373 
MG) cells by tachykinins and related analogues: SP ( 0 ) 
,[GI~6,L-prO]-sp (6-11) (.6), NKA ( • ), NKB (0 ), and 
[GIp ,D-Pro]-SP (6-11) (+). Each point is a mean ± S.D. of 






Comparison of potencies of mammalian tachykinins 
and their analogues in stimulating [3HJ-taurine release from 
human astrocytoma (U-373 MG) cells. 
Peptides EC50 * ,(nM) 
Substance P (SP) 0.31 ± 0.06 (n - 6) 
Neurokinin A (NKA) 20 ± 5 (n - 2) 
Neurokinin B (NKB) 200 ± 35 (n - 2) 
[Glp6, D-pro9 J-SP(6-11) 3630 ± 480 (n - 4) 
[Glp6, L-pro9 J-SP(6-11) 20 ± 10 (n = 3) 
Each value is a mean ± S.D. of (n) separate experiments. *EC5Q is I 
the concentration of peptide required to give half-maximal st~mu­
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Figure 3.4 
Effect of spantide on SP-induced [3HJ-taurine. To investigate 
the effect of 1 pM ( .. ) and 10 pM (~) of spantide on SP-
induced [3HJ-taurine release, cells were pretreated with the 
indicated concentration of spantide for 15 min before the addi-
tion of SF. Open circle ( 0 ) represented the SP response without 
spantide pretreatment. Each point is the mean ± S.D. of tripli-
cate deterrninations. Similar results were obtained in 3 separate 
experiments. 
3.2.3 THE INTERACTION BETWEEN SP- AND IPR-STIMULATED TAURINE 
RELEASE 
3.2.3.1 CONCENTRATION DEPENDENCE OF IPR-INDUCED RELEASE OF [3 H]_ 
TAURINE 
IPR, a fi-adrenergic agonist was able to stimulate the release 
of [3HJ-taurine from U373 MG astrocytoma cells in a concentration 
dependent manner (Figure 3.5). Its EC50 was 10 ± 1 nM (mean ± 
s. D., n=7). At 100 nM, IPR gave a 3-fold stimulation over the 
basal release of taurine. 
3.2.3.2 EFFECT OF 100 nM IPR ON SP-STIMULATED TAURINE RELEASE 
since both IPR and SP can stimulate [3HJ-taurine release from 
astrocytoma cells, it is logical to examine whether there is an 
interaction between these 2 chemicals In their regulation of 
taurine release. The effect of a submaximal dose of IPR (100 nM) 
on the taurine release stimulated by different concentrations of 
SP (0.1-100 nM) was studied. 
The results shown in Figure 3.6 indicated that the effects of 
SP and IPR on the [3HJ-taurine release were simply additive. For 
instance while 100 nM IPR and 100 nM SP alone stimulated release 
by 243 ± 23% and 505 ± 16 % respectively, the simultaneous addi-
tion of 100 nM SP and 100 nM IPR stimulated release by 687 ± 91% 
over the basal release. 
3.3 SECOND MESSENGER SYSTEMS INVOLVED IN THE REGULATION OF'. 
TAURINE RELEASE BY SP AND IPR 
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[ISOPROTERENOL] (n~l) 
Figure 3.5 
Concentration dependence of isoproterenol-stimulated [3HJ-taurine 
release from human . astrocytoma (U-373 MG) cells. Each point is 
the mean ± S.D. of triplicate determinations. Similar results 
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Figure 3.6 
Effect of 100 nM isoproterenol on SP-induced [3HJ-taurine release 
from human astrocytoma (U-373 MG) cells. Open circle ( 0 ) and 
filled triangle ( • ) represent SP-induced [3HJ-taurine release 
in the absence and presence of 100 nM IPR, respectively. 100 nM 
IPR alone induced a 243 ± 23% of basal release. Data are the 
means ± S.D. of triplicate determinations. Similar results were 
obtained in three separate experiments. 
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3.3.1 THE ROLE OF cAMP 
IPR is a ~-adrenergic agonist which can stimulate the accumu-
lation of cAMP in variety of tissues and cells. Therefore, it was 
suspected that the effect of IPR on taurine release from astrocy-
toma cells may be mediated by an activation of the adenylate 
cyclase cAMP pathway. To shed light on the role of cAMP level in 
the release of [3HJ-taurine from astrocytoma (U-373 MG) cells, 
the effects of IPR and SP on cAMP levels were examined. 
The resul ts shown in Figure 3.7 indicated that 1 J.1.M IPR 
increased cAMP level in astrocytoma cells to 3 times of the basal 
level. On the other hand, 1 J.1.M SP had no effect on the basal cAMP 
level and it did not alter the IPR-induced cAMP accumulation. 
To further evaluate the role of cAMP in the regulation of 
taurine release from astrocytoma cells, the effect of N6 , 0 2-
dibutyryl cAMP (dbcAMP) was examined. As shown in Figure 3.8, 
1 mM dbcAMP stimulated [3HJ-taurine release although its effect 
was lowered than that induced by 100 nM isoproterenol. 
3.3.2 THE ROLE OF PHOSPHATIDYLINOSITOL BISPHOSPHATE ~PIP2) METAB-
OLISM 
It hap been reported that some SP receptors are coupled to 
the PI/PLC pathway (Quirion & Dam, 1988). In order to define the 
involvement of the PI/PLC pathway in the SP-induced taurine 
release, the effect of SP on the hydrolysis of PIP2 in U373 MG 
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Effects of 1 ~M SP and/or 1 ~M IPR on the cAMP level of U373 MG 
cells. cAMP levels were determined by a cAMP assay kit from 
Amersham. Each column represents the mean ± S.D. of quadruplicate 
deterrninations from a typical experiment. Similar results were 



















































Effects of dbcAMP (1 mM) and IPR (100 nM) on [3H]-taurine re-
lease. Each column represents the mean ± S.D. of triplicate 
deterrninations from a typical experiment. Similar results were 
obtained in two separate experiments. 
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3.3.2.1 TIME COURSE OF SP-INDUCED INOSITOL PHOSPHATES ACCUMULATION 
The hydrolysis of PIP2 can be conveniently measured by deter-
mining the level of inositol phosphates (IPs) including inositol 
trisphosphate (IP3 and its phosphorylated and dephosphorylated 
products). SP (100 nM) induced a time dependent accumulation of 
IPs in U-373 MG cells. As illustrated in Figure 3.9, the level of 
IPs increased gradually after 1 min exposure to SP and reached a 
plateau in 30 min. Increasing the incubation time with SP beyond 
30 min did not further increase the level of IPs. Therefore, a 30 
min incubation time was chosen in subsequent experiments. 
3.3.2.2 PHARMACOLOGICAL STUDIES OF SP-INDUCED IPs ACCUMULATION 
SP increased the accumulation of IP I S in a concentration-
dependent manner (Figure 3.10). The ECSO of SP was 0.43 ± 0.28 nM 
(mean ± S.D.,n=6). At 100 nM, SP increased the level of IPs by 2 
to 3-fold over the basal level. 
NKA also increased the level of IPs concentration dependently 
with an EC50 of 35 ± 14 nM (mean ± S.D., n= 2 ). These effects of 
SP and NKA were remarkably similar to their effects in stimulat-
ing the release of taurine (compare Figures 3.3 & 3.10). 
Moreover, spantide (10-30 ~M) concentration dependently 
inhibited the effect of SP on IPs accumulation (Figure 3.11). 
The inhibitory effect of 30 ~M spantide was greater than that bf 
10 ~M spantide. Spantide at 10-30 ~M had little or no effect by 
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Figure 3.9 
Time dependent increase in [3H]-inositol phosphates accumulation 
induced by SP (100 nM). Data shown are the means ± S.D. of trip-
licate determinations from a typical experiment. Similar results 
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stimulation of [3HJ-inositol phosphates (IPs) accumulation in 
human astrocytoma (U-373 MG) cells by SP ( 0 ) and NKA ( .). 
Data given are the means ± S.D. of triplicate determinations. 
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Figure 3.11 
Effect of spantide on SP-induced [3HJ-inositol phosphates (IPs) 
accumulation. Cells were pretreated with 10 ~M ( • ) or 30 ~M 
( A) of spantide for 15 min before the addition of SP. Open 
circle (0) represents the SP response without spantide pre-
treatment. Data shown are the means ± S.D. of triplicate deter-
minations from a typical experiment. Similar results were ob-
tained in two separate experiments. 
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3.3.2.3 EFFECT OF SP ON INOSITOL TRISPHOSPHATE (IP3) 
Among the inositol phosphates formed after the hydrolysis of 
PIP2 by PLC, IP3 plays an important role in mobilizing intracel-
lular ca2+. The formation of IP3 is transient as it will be 
metabolized quickly to other inositol phosphates such as IP1 , 
IP2 and so on. In order to measure the formation of IP3 , the 
reaction was terminated after the cells were incubated with 1 ~M 
SP for 15-45 sec. The 3H-inositol phosphates were resolved by 
anion exchange chromatography_ A typical elution profile of the 
inositol phosphates was depicted in Figure 3.12. After 15 sec 
incubation with SP, the [3HJ-IP3 level was 200% of the control 
level. However, when the incubation time was increased to 45 sec, 
the [3HJ-IP3 level was only 136% of the control level (Table 
3.9) • 
3.3.2.4 EFFECT OF IPR ON IPs ACCUMULATION 
In order to understand the mechanism underlies the additive 
effect of SP and IPR on taurine release, the effects of 100 nM 
IPR and 10 nM SP on the accumulation of IPs were examined. The 
results presented in Figure 3.13 indicated that 100 nM IPR had no 
effect by itself and it did not affect the accumulation of IPs 
induced by 10 nM SP. 
3.3.3 THE ROLE OF Ca2+ MOBILIZATION 
The hydrolysis of PIP2 will produce IP3 and diacylglycerol. 
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Figure 3.12 
Typical elution profile of [3HJ-inositol phosphates on an anion 
exchange column. Reactions were terminated after the cells were 
exposed to 1 ~M SP ( 0 ) or buffer (. ) for 15 sec. 5 ml eluent 
per fraction was collected as described in method. 
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Table 3.9 





Treatment [3HJ-IP1 [3 H]-IP2 [3 H]-IP3 
15 control 499 ± 33 86 ± 8 81 ± 4 
SP (1 J.LM) 544 ± 16 174 ± 7 160 ' ± 7** 
45 control 386 ± 84 91 ± 11 85 ± 3 
SP (1 J.LM) 469 ± 44 123 ± 7 1-16 ± 7* 
Reactions were terminated after the cells have been incubated 
with 1 J.LM SP or buffer for 15 sec and 45 sec. The radioactivity 
associated with the inositol phosphates -were determined after 
separation on an anion exchange column. *,p < 0.05; **,p < 0.005 
when compared with controls using student's t-test. Results are 
the means ± s.o. of triplicate determinations. 
Table 3.10 
Effect of extracellular Ca 2+ 
on the A23187-induced [3 H]-taurine release 
[3HJ-Taurine release 
Incubation medium (% of basal release) 
Normal PSS 
PSS (CaC1 2 + 1 mM EGTA) 1 J.LM A23187 in normal PSS 
1 J.LM A23187 in PSS (CaC1 2 
+ 1mM EGTA) 
100 ± 20 
115 ± 2 
1680 ± 74 * 
485 + 47 * 
Results are the means ± S.D. of triplicate determinations. Simi-
lar results were obtained in two separate experiments. *,p < 0.02 
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Effect of IPR and SP on the accumulation of [3HJ-inositol phos-
phates in U-373 MG astrocytoma cells. Each column represented the 
mean ± S.D. of triplicate determinations. Similar results were 
obtained in two separate experiments. 
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cytosolic Ca 2+ from both internal and external sources (Berridge, 
1987). Since SP can stimulate the accumulation of IPs and IP3 
. 2+ (see section 3.3.2), an increase in intracellular Ca may there-
fore play a role in the regulation of taurine release from astro-
cytoma cells. Indeed, A23187, a calcium ionophore, markedly 
stimulated [3HJ-taurine release in a concentration dependent 
manner (Figure 3.14). The ECSO of A23187 cannot be determined as 
taurine release did not reach a -plateau up to 10 ~M of A23187. 
This effect of A23187 was dependent on the extracellular Ca 2+ 
level. In the absence of extracellular ca2+, the effect of A23187 
on [3HJ-taurine release was markedly reduced (Table 3.10). 
To examine the possible interaction between cAMP and Ca 2+ as I 
regulators of taurine release, the effects of 1 ~M A23187 with or 
without 100 nM IPR were investigated. The results indicated that 
the responses of 1 ~M A23187 and 100 nM IPR were additive 
(Figure 3.15). 
3.3.4 THE ROLE OF PROTEIN KINASE C (PKC) 
An increase in PIP2 hydrolysis will result in the production I 
of IF3 and diacylglycerol. Diacylglycerol in turn can stimulate 
the activity of PKC (Nishizuka, 1984). Therefore, PKC may also be 
involved in the regulation of taurine release by SP. In order to 
study the role of PKC in the regulation of taurine release, a 
phorbol ester, phorbol-12-myristate-13-acetate (PMA) was employed 
to activate PKC directly in intact cells. 
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3.3.4.1 CONCENTRATION DEPENDENCE OF PMA-STIMULATED TAURINE RE-
LEASE 
PMA increased [3 H]-taurine release from astrocytoma (U-373 
MG) cells in a concentration dependent manner with an EC50 of 4 
nM (Figure 3.16). At 100 nM, PMA produced a 4 fold increase ir 
[3 H]-taurine release. 
3.3.4.2 EFFECT OF H7 ON THE RELEASE OF TAURINE 
In a variety of studies, it has been reported that H7 
[1-(5-isoquinoline sulfonyl)-2-methyl piperazine] can inhibit 
some or all of the effects elicited by PKC activation (Hidaka & , 
Hagiwara, 1987). In order to define the role of PKC in the regu- I 
lation of SP-stimulated taurine release, the effect of H7 was 
studied. 
Neither 10 ~M nor 30 ~M H7 had a significant effect on both 
the basal and 1 nM SP-stimulated taurine release (Figure 3.17). 
However, the presence of 100 ~M of H7 stimulated both the basal I 
and the SP-stimulated taurine release by 35 ± 26% (mean ± S.D., 
n=6) and 10 ± 1% (mean ± S.D., n=3) respectively. Thus, 100 ~M 
H7 exerted a small stimulatory effect on both the basal and 1 nM 
SP-stimulated taurine release. 
Although H7 did not inhibit the SP-stimulated taurine re-
lease as expected, it does not necessarily rule out the role of 
PKC in this response. Maybe, for some unknown reason, H7 could 
not inhibit the PKC in the U373 MG astrocytoma cells. In order to 
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Figure 3.14 
Effect of A23187 on [3HJ-taurine release from human astrocytoma 
(U373 MG) cells. Results are the means ± S.D. of triplicate 
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BASAL IPR A23187 IPR + A23187 
Figure 3.15 
Effect of IPR and A23187 on [3HJ-taurine release from U373 MG 
astrocytoma cells. Each column represents the mean ± S.D. of 
triplicate determinations from a typical experiment. *,p<O.02 
when compared with the response of A23187 alone. 
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PMA-stimulated taurine release was studied. As illustrated in 
Figure 3.16, H7 (100 ~M) instead of inhibiting the PMA-stimulated 
taurine release, it actually potentiated the response of PMA. The 
potentiating effect of 100 ~M H7 seemed to increase with increas-
ing concentrations of PMA. However, the EC50 of PMA-stimulated 
taurine release from astrocytoma cells was the same in the 
presence or absence of 100 ~M H7.To examine whether H7 altered 
the hydrolysis of PIP2 , its effect on the accumulation of inosi-
tol phosphates was studied. As illustrated in Figure 3.18, 
neither 100 ~M H7 nor 100 nM PMA had any affect on the basal 
accumulation of [3 H]-IPS . However a combination of 100nM PMA 
with 100 ~M H7 inhibited slightly the accumulation of 
However, the inhibitory effect of H7 and PMA is unclear. 
3.3.4.3 EFFECT OF STAUROSPORINE ON TAURINE RELEASE 
It has been reported that H7 1S not a selective PKC inhibi-
tor and it also inhibits other protein kinases (Huang,1989). 
Therefore, a more potent and specific PKC inhibitor, staurospo-
rine, was used to study the role of PKC in the SP and PMA-
stimulated taurine release. 
Preincubation with staurosporine for 15 min resulted in a 
concentration dependent inhibition of [3 H]-taurine release 
induced by PMA (100 nM) (Figure 3.19). Increasing the preincuba-
tion time with staurosporine (1 ~M) to 90 min resulted in a 
slightly higher degree of inhibition (Figure 3.20). However, it 
did not completely inhibit the [3 H]-taurine release stimulated 





































Effect of 100 ~M H7 ( • ) on the PMA induced ( 0) [3H]-taurine 
release from human astrocytoma (U-373 MG ) cells. 100 ~M H7 
stimulated [3H]-taurine release to 179 ± 14% of basal release. 
Results are the means ± S.D. of triplicate determinations from a 















[ H7 ] (p,M) 
Figure 3.17 
Effect on H7 on the basal ( 0 ) and SP-stimulated (. ) [3 HJ -
taurine release. Data given are the mean ± S.D. of triplicate 
determinations. 1 nM SP stimulate [3HJ-taurine release to 
255 ± 13% of basal release. 
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tested since in preliminary experiments 10 MM of staurosporine 
was found to stimulate [3HJ-taurine to 320 ± 20% of basal re-
lease by itself. 
In contrast with H7, the pretreatment of cells with 1 MM 
staurosporine for 15 min inhibited [3HJ-taurine release induced 
by SP (Figure 3.21). However, as in the case of PMA, the inhibi-
tion was not complete and about 50% of the response induced by 
100 nM SP was still observed after staurosporine pretreatment. 
It should be noted that 1 ~M staurosporine pretreatment did not 
alter the basal release of [3HJ-taurine by itself. 
3.3.4.4 EFFECT OF CHRONIC PMA PRETREATMENT 
An alternative approach to study the role of PKC in the 
regulation of taurine release would be the preparation of PKC-
deficient cells. Prolonged treatment with phorbol .esters has been 
reported to decrease total PKC activity to eventually undetect-
ably levels (Yamasaki et. al.,1980). 
PMA was dissolved in 100% DMSO and the final concentration 
of DMSO in 10 MM PMA was 0.1%. This concentration of DMSO had no 
effect on the basal [3HJ-taurine release (Table 3.12). More-
over, the pretreatment of cells with medium containing 0.1% DMSO 
for 19 h had no effect on either the uptake (Table 3.13) or the 
basal and SP-stimulated release of [3HJ-taurine (Table 3.12). 
After the pretreatment of cells with 10 MM PMA for 19 h, the 
uptake of [3HJ-taurine was about 10% less than that of the 
untreated cells (Table 3.13) .The same pretreatment, however 
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Effect of PMA and H7 on [3HJ-inositol phosphates accumulation in 
°astrocytoma (U-373 MG ) cells. Results are the means ± S.D. of 
triplicate determinations from a typical experiments. Similar 
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Figure 3.19 
Effect of staurosporine on the PMA-stimulated taurine release. 
Cells were pretreated with the indicated concentration of stau-
rosporine before the addition of 100 nM PMA. PMA alone stimulated 
[3HJ-taurine release to 724 ± 24% of the basal release. Date 
shown are the means ± S.D. of triplicate determinations. Similar 




























~ 60 ~ 0 
~ '-~~Q ~ 









0 15 30 45 60 75 90 
TTrv'fR (MTN) 
Figure 3.20 
Time dependence ~f the inhibitory effect of staurosporine on the 
PMA-stimulated [ HJ-taurine release. Cells were pretreated with 1 
~M staurosporine for the indicated time before the addition of 
100 nM PMA. The pretreatment of the cells with staurosporine did 
not alter the basal rele~se. without staurosporine pretreatment 
100 nM PMA stimulated [HJ-taurine release to 477 ± 34% of the 
basal release. Data shown are the'means·± S.D. of triplicate 
determinations. Similar result were obtained in two separate 
experiments. 
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to PMA (Figure 3.22) and partially inhibited the response to SP 
(Figure 3.23). The inhibitory effect of chro"nic PMA pretreatment 
was more apparent at higher SP concentrations and as much as 40% 
of the response was inhibited at 100 nM SP. 
On the other hand, chronic PMA (10 ~M) pretreatment did not 
inhibit the IPR-stimulated [3HJ-taurine release (Figure 3.24). 
The small increase of IPR response after PMA pretreatment was due 
to the increase of basal release of [3HJ-taurine. 
3.3.4.5 MEASUREMENT OF PKC ACTIVITY 
In addition to the pharmacological manipulation of PKC 
activity, the role of PKC in the regulation of taurine release 
was also studied by measuring the enzyme activity directly. The 
ability of the soluble and particulate fractions of U373 MG 
astrocytoma cells to catalyse the incorporation of the r-phos-
phate group of [r-32 PJ-ATP into lysine-rich histo~e was measured 
with and without the addition of Ca 2+ (2 mM) and PS (20 ~g/ml). 
The PKC activity was defined as the amount of radioactivity 
incorporated into histone in the presence of both Ca2+ and PS 
minus that in their absence. As shown in Figure 3.25,about 70% of 
the PKC activity in the U-373 MG astrocytoma cells was found in 
the cytosolic fraction under normal conditions. Upon exposing the 
cells to 100 nM SP, there was a time dependent decrease in the 
PKC activity in the cytosolic fraction accompanied by an increase 
in the membrane PKC activity (Figure 3.26). The membrane bound 
PKC activity reached a maximum after 1 min incubation with SP 
where 65% of the PKC activity was found in the membrane. After 5 ~ 
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Effect of staurosporine pretreatment on SP-induced 
release. Cells were pretreated for 15 min with 1 ~M 
(. ) or buffer ( 0 ) before the addition of SP. 
ment of the cells with 1 ~M staurosporine for 15 
alter the basal level. Results are the means ± S.D. 












Effect of Chronic PMA pretreatment on basal 
and SP-stimulated [3HJ-taurine release 
[3HJ-taurine release 
(% of basal release) 
Buffer 100 nM 
100 ± 1 351 ± 
SP 
33 
PSS + 0.1% DMSO 100 + 10 - - -
0.1% DMSO pretreatment for 19 h 107 ± 14 330 + 29 
10 MM PMA pretreatment for 19 h *171 ± 12 263 ± 14 
Results are the means ± S.D. of triplicate determinations. Simi~ 
lar results were obtained in two separate experiments. *,p < 0.01 
when compared with normal PSS using student's t-test. 
Table 3.13 
Effect of chronic PMA pretreatment on the uptake of [3HJ-taurine 
into U-373 MG astrocytoma cells 
Pretreatment 
Normal medium 
Medium with 0.1% DMSO for 19 h 
Medium with 10 MM PMA for 19 h 
% of [3HJ-taurine uptake 
68.6 ± 1.7 
68.4 ± 0.5 
61.1 ± 0.4 * 
Results are the means ± S.D. of triplicate determinations. *,p < 
















~ T , 
""-./ 
• • • 
100 I 
1 J 
I I I 
0.01 0.10 1.00 10.00 
[PM~L\.J (JLlY1) 
Figure 3.22 
Effect of chronic PMA pretreatment on PMA-induced [3HJ-taurine 
release. Cells were pretreated with 10 ~M PMA for 19 h before 
they were tested for PMA-induced [3HJ-taurine release. After 
chronic PMA pretreatment, basal [3HJ-taurine release increased 
by 55 ± 0.6%. Open circle ( 0 ) and filled circle ( • ) represent 
PMA responses by the untreated and treated cells respectively. 
Data are the mean ± S.D. for triplicate determinations. Similar 
result were obtained in three separate experiments. 
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Figure 3.23 
Effect of chronic PMA pretreatment on SP-induced [3H]-taurine 
release. Cells were pretreated with 10 ~M PMA for 19 h before the 
effect of SP was tested as described in met'hod. A5ter chronic PMA 
pretreatment of the cells, basal release of [H]-taurine in-
creased 84 ± 1.3%. Open circle ( 0 ) and filled circle ( • ) 
represented SP response by the untreated and treated cells re-
spectively. Results are the means ± S.D. of triplicte determina-
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Effect of chronic PMA pretreatment on IPR-stimulated [3HJ-taurine 
releas!. After 19 h PMA (10 ~M) pretreatment, the basal release 
of [H]-taurine increased by 92 ± 2.7%. Open circle (0 ) and 
filled circle (.) represented IPR response by untreated and 
treated cells, respectively. Data given are the means ± S.D. for 
triplicate determination. Similar results were obtained from four 
separate experiments. 
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ruin incubation with SP, the membrane bound PKC activity gradually 
~ 
returned to the basal level. After the cells were pretreated with 
10 ~M PMA for 19 h, the PKC activity in the cytosol was complete-
ly lost and less than 30% of the PKC activity was found to remain 
in the membrane fraction (Table 3.14). The ability of H7 and 
staurosporine to inhibit PKC activity was also confirmed. The 
treatment of the particulate and cytosolic fractions with 100 ~M 
H7 inhibited 80% of the PKC activity while 1 ~M staurosporine 
completely inhibited the PKC activity in both cytocolic and 
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Figure 3.25 
The ability of the soluble and particulate fractions of astrocy-
toma (U-373 MG ) cel\s to catalyse the incorporation of T-
phosphate gro~ of [T- 2pJ -ATP into histone in the presence or 
absence of Ca + (2 mM) and/ or PS (20 J,.Lgjml) . Results are the 
means ± S.D. of triplicate determinations from a typical experi-
ment. Similar results were obtained in 3 separate experiments. 
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Figure 3.26 
The translocation of PKC induced by SP (100 nM).( 0 ) and ( • ) 
circle represent supernatnat and particulate fractions res~ec-
tively. PKC activity was defined as the amount of 2p. 
radioacti vi ty incorporate into histone in the presence or 
Ca2+ and PS minus that in their absence. Results are the means ± 
S.D. of duplicate determinations. Similar results were obtained 
in three separate experiments. 
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Table 3.14 
Effect of Chronic PMA pretreatment 
on the PKC activity of U-373 MG astrocytoma cells 
Pretreatment 
Normal medium 
PKC activity (CPM) 
(cpm of 32pi incorporated into histone) 
soluble particulate 
Medium with 10 MM PMA for 19 h 
38839 ± 5646 
o 
30879 ± 2678 
8840 ± 2900 
PKC activity was defined as the amount of 32pi radioactivity 
incorporate into histone in the presence of ca2+ and PS minus 
that in their absence. Results are the means ± S.D. of duplicate 
determinations.Results are the means ± S.D. of duplicate determi-




PMA (1 MM) 
H7 (100 MM) 
Staurosporine 
H7 (100 MM) + 
Staurosporine 
+PMA (1 MM) 
Table 3.15 
Effect of H7 & Staurosporine on cytosolic 
and particulate protein kinase C activity 
on human astrocytoma (U-373 MG) cells 
PKC Activity 
(cpm of 32pi incorporated into histone) 
supernatant particulate 
40333 ± 5660 30741 ± 2026 
44375 ± 1758 37691 ± 4401 
11183 ± 489 5551 ± 1497 
(1 MM) 0 0 
PMA (100 MM) 8173 ± 404 7788 ± 1411 
(1 MM) 
0 0 
Drugs were added to cytosolic and particulate fractions when the 
initiation of PKC activity assay. PKC activity was defined as 
described in Table 3.14. Results are the means ± S.D. of dupli-






CHAPTER FOUR. DISCUSSIONS 
The present study concentrates mainly on - the biological 
consequences trigge~ed by SP receptor activation in human astro-
cytoma cells (U-373 MG). A tumour cell line was employed in this 
study since it has many advantages over other experimental sys-
tems such as tissue slices, cell isolates and primary cultures. 
Tissue slice studies are complicated by the fact that they are 
multi-cellular systems, which makes it difficult to attribute 
experimentals result to any individual cell type. Cells freshly 
isolated from animals are often damaged or contaminated with 
other cell types. The characteristics of primary cultures can 
vary from preparation to preparation and they often change their 
properties during aging in culture. One should, however, also 
exercise caution when extrapolating results from tumour cells to 
normal cells. 
4.1 A COMPARISON OF THE CHARACTERISTICS OF RELEASE OF TAURINE 
FROM ASTROCYTOMA CELLS AND NEURONS. 
It has been demonstrated that high potassium concentration 
can depolarize the astrocyte cell membrane by an increase in K+ 
influx through the voltage-dependent K+ channels (Enkvist et. 
al., 1988; Brisman & Collin, 1989). Since cultured glial cells 
also possess voltage sensitive ca2+ channels (Tas et. al., 1988; 
MacVicar, 1984), it is suspected that glial cells may release 
"glio-transmitter" in a calcium dependent manner in response to 
high extracellular potassium concentration. However, the K+-
evoked taurine release was calcium-dependent in neuronal cells 
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but not in astrocytes, and it has been suggested that the K+-
evoked release of taurine was originated from synaptic vesicles 
in granule cells but not in astrocytes (Holopainen et. al., 
1989). MQreover, calcium independent K+ (56 mM) -evoked taurine 
release has also been demonstrated in astrocyte culture from 
cerebral cortex (Pasantes-Morales & Schousboe, 1989). On the 
other hand, high external K+ (10-80 mM) have evoked been reported 
to a dose-dependent and ca2+-dependent taurine release from 
cultured astrocytes (Philibert et. al., 1988). The reason for 
this discrepancy is not known at present. 
In the present study, increasing. concentration of K+ (Table 
3.4) or lowering concentration of ca2+ (Table 3.5) in the medium 
did not have any effect on the basal release of [3H]-taurine from 
U-373 MG cells. The discrepancy of depolarizing concentration of 
potassium in eliciting a [3HJ-taurine release response between 
primary . culture of astrocyt~s and astrocytoma cells may be due 
to the tumour origin of the U-373 MG cell line. Human astrocytoma 
with a variety of electrical traits have been described, resting 
membrane potentials recorded from human glioblastoma in culture 
have been low, ranging from -10 to -27 mV. However, the resting 
membrane potential of astrocytes 1S about -70 mV, which have been 
shown to be almost purely K+-dependent in human (Lomneth et. al., 
1989). Understanding the properties of the K+, ca2+, Na+ and Cl-
channels in U-373 MG astrocytoma cells wfll help to understand 
the cause of their the non-responsiveness to of high K+ concen-
tration stimulation. It should, however, be mentioned that an 
absence of response to high concentration of potassium have also '. 
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been reported in primary cultured astrocytes (Flint et. al., 
1981; McBride et. al., 1983). 
It has been postulated that Mg 2+ ions can oppose ca2+ in the 
release of transmitters and thus block synaptic transmission 
(Czeh & 'Somjeu, 1989). Schousboe and Pansantes-Morales (1989) 
have demonstrated that the stimulatory effect of K+ on taurine 
release from cortical neurons was decreased in medium containing 
no Ca2+ and high MgS04 (20 mM). However, both basal and SP-in-
duced taurine release in a medium of low Ca2+ (0.1 mM) and high 
Mg2+ (10mM) were not significantly different from that in the 
normal medium (Table 3.5). Therefore, the mechanism of taurine 
release from (U-373 MG) astrocytoma cells is clearly different 
from the conventional voltage sensitive, calcium dependent vesic-
ular release from neurons. 
Yuasa and Hamprecht (1987) have recently reported that the 
taurine transport in glioma cells and primary culture of astro-
cytes is dependent on the Na+ gradient. Intracellularly accumu-
lated taurine was released from neuroblastoma x glioma cells 
108CC5 only if the intracellular concentration of sodium is 
raised and the taurine transporter and taurine gradient have the 
function of a Na+ pump supplementary to the Na+/K+-ATPase. 
The basal release of [3HJ-taurine in U-373 MG was sodium 
dependent and the replacement of sodium by choline in PSS caused 
an increase of [3HJ-taurine release from astrocytoma cells (Table 
. , 
3.3 and Figure 3.2). The enhancement of [3HJ-taurine release from 
astrocytoma cells in sodium-free medium may be explained by a 
carrier-mediated efflux of [3HJ-taurine owing to a redistribution 
of the orientation of taurine transport sites in the plasma 
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membrane as a result of the change in Na+ gradient (Oja & Kon-
tro, 1987). Alternatively, the increase in release can also ex-
plained by a change in balance between uptake and release of 
taurine. Since [3HJ-taurine can be taken up into the cells via a 
sodium dependent mechanism (Table 3.3), as sodium concentration 
in the medium is lowered, there will be a corresponding decrease 
in uptake which can give rise to an apparent increase in release. 
The increase in taurine release induced by SP, however, was not a 
result of an inhibitory effect of SP on the sodium dependent 
uptake since its effect was not affected by the absence of sodium 
in the medium (Table 3.3). 
The decrease in SP-induced taurine release by high extracel-
lular K+ (Table 3.4) may be due to a change in the transmembrane 
ionic gradient since taurine transport is dependent on the Na+ 
gradient (Oja & Kontro, 1987). In addition, both basal and SP-
induced [3HJ-taurine release were temperature dependent (Table 
3 • 6) • The temperature dependency of the sodium pump may be the 
reason for the temperature-dependence of taurine release. 
4.2 SP-INDUCED [3H]-TAURINE RELEASE FROM U-373 MG ASTROCYTOMA 
CELLS. 
According to radioligand binding and biological experiments, 
three distinct types of tachykinin r~ceptqrs have been identified 
(Lee et. al., 1986; Regoli et. al., 1987)'. At the neurokinin-l 
(NK-1) receptor, SP is more active than NKA and NKB and [Glp6, 
L-pro9 J-SP(6-11) is more active than [Glp6, D-pro9 ]-SP(6-11) (Lee ~ 
et. al., 1986). Unfortunately, highly selective and potent NK-1 
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receptor antagonists are not available at the present time 
(Regoli, et. al., 1987). NK-1 receptors are widely distributed in 
peripheral and brain tissues. The dog carotid artery, guinea pig 
urinary pladder and the rat salivary gland, constitute typical 
NK-1 bio-assay tissues because of their high densities of NK-1 
sites. 
NKA is the preferential ligand for the neurokinin-2 (NK-2) 
receptor (Masu et. al., 1987). However, other non-mammalian 
tachykinins, including eledoisin and kassinin, also possess good 
affinities for this receptor subtype (Lee et. al., 1986). 
[Nle10J-NKA is a fairly selective ag~nist for the NK-2 receptor 
(Quirion & Dam, 1988). In tissues enriched in NK-2 receptors 
(including hamster urinary bladder and rat vas deferens), [Glp6, 
D-pro9 J-SP(6-11) is much more active than [Glp6, L-pro9 J-sP-(6-
11) (Lee et. al., 1986). Neurokinin-3 (NK-3) receptors possess 
high affinity for NKB and [Glp6', D-pr09 ]-SP(6-11) is slightly 
more active than [Glp6, L-pro9 J-SP(6-11) (Lee et. al., 1986). 
Lee and coworkers (1989) have recently demonstrated the pre-
sence of a functional NK-1 type tachykinin receptor on human 
astrocytoma cells (U-373 MG) by radioligand binding and uridine 
incorporation experiments. In the present study, SP was found to 
stimulate the release of [3HJ-taurine from these cells with high 
potency (ECSo=O.31 nM) . This is comparable to its ability in 
inhibiting [125 I ]-BHSP binding (ICS~=O.3Y nM) to the same cells 
(Lee et. al., 1989). Among the tachykinins tested, SP was the 
most potent in stimulating [3 H]-taurine release and the rank 
order of potency was SP» NKA » NKB. Moreover, [Glp6 , .'. 
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L-pro9 J-SP(6-11) was 180 times potent than [Glp6, D-pro9 J-SP(6-
11) in stimulating [3HJ-taurine release ( 'Table 3.8 and Figure 
3.3). Thus the pharmacological profile of SP receptors on U373 MG 
cells determined in the present eXJ?eriment is very similar to 
that observed for the NK-1 sites in the rat salivary gland (Lee 
et. al., 1986). Spantide is a SP receptor antagonist which has 
been shown to block SP-evoked reponses in peripheral tissues 
(Folkers et. al., 1984) and in the eNS (Petit & Glowinski, 1986). 
The present study indicates that spantide concentration-
dependently antagonized the SP stimulatory effect on [3HJ-taurine 
release. This provides further support for the existence of 
specific SP receptors in human astrocytoma (U-373 MG) cells. 
4.3 THE ROLE OF SECOND MESSENGER SYSTEMS IN THE SP-INDUCED [3H]-
TAURINE RELEASE 
Activation of NK-1 receptor has been shown to stimulate 
phosphatidylinositol turnover in the salivary gland (Hanley et. 
al., 1980). The present study indicates that SP can stimulate 
inositol phosphates (IPs) accumulation in intact astrocytoma 
cells presumably as a result of PIP2 hydrolysis, a finding in 
agreement with results obtained by others working on brain slices 
(Watson & Downes, 1983; Mantyh et. al., 1983; Hunter et. al., 
1983). Both SP and NKA stimulated the accumulation of inositol 
phosphates with high potency, with EC50 of- 0.43 and 35 nM respec-
tively. These correlated very nicely with their effects in stimu-





The hydrolysis of PIP2 will generat~ at least two second 
messenger molecules, inositol trisphosphate (IP3 ) and diacylgly-
cerol (DAG) which in turn can elicit the release of intracellular 
calcium and activate PKC respectiv~ly. In order to define the 
role of calcium and PKC in SP-stimulated taurine release, A23187~ 
(a calcium ionophore), arid PMA (a PKC acitvator), were employed 
to mimic the effects of the endogenous second messengers IP3 and 
DAG. 
As mentioned in section 4.1,the taurine release from U-373 MG 
astrocytoma cells was independent of calcium levels in the medi-
um. However, these data do not indicate whether taurine release 
I 
from astrocytoma cells is dependent on ca2+ mobilized from intra-
cellular stores. In order to investigate the effect of free 
cytoplasmic Ca2+ ([ca2+Ji) on astrocytic taurine release, [ca2+Ji 
was manipulated by using a calcium ionophore in the presence of 
different concentrations of calcium in the medium. 
As shown in Figure 3.14 and Table 3.10, A23187 markedly in-
creased the release of [3 H]-taurine from astrocytoma cells. This 
effect was decreased significantly when cells were incubated in 
a medium devoid of extracellular calcium (CaCl 2-free PSS contain-
ing 1 mM EGTA). These results suggested that an increase in 
cytosolic calcium can facilitate [3HJ-taurine release from human 
astrocytoma cells (U-373 MG). It should be noted that although 
A23187 has been shown to increase the intracelllular concentra-
. -
tion of both total and free Ca 2+ within a few second of exposure 
(Campbell & Dormer, 1978), this is not the only action of this 
drug (Pfeiffer et. al.,1978). A23187 has recently been demon-
strated to stimUlate inositol phospholipid turnover in cultured 
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astrocytes (Pearce et. al., 1986). Therefore, the effect of 
A23187 may not be solely due to the change of [ca2+Ji. Since Fu 
and coworkers (1988) have demonstrated that chelation of extra-
cellular Ca2+ with 1 mM EGTA caused marked inhibition of bradyki-
nin-induced Ins(1,4,5)P3 production in fibroblasts and neuroblas-
toma cells it is possible that the decrease of A23187-induced 
taurine release in CaCl 2 free PSS containing 1 mM EGTA may be due 
to the decrease of IP3 production in astrocytoma cells. Further 
study will be required to evaluate this possibility. 
It has been reported that IP3 can cause an increase in 
cytosolic calcium from both internal and external source of Ca2+ 
( Berridge, 1987). Transient increase in Ins(1,4,5)P3 evoked by 
SP (1 ~M) have been reported to mediate Ca2+ entry as well as 
internal Ca2+ release in parotid cells (Merritt & Rink, 1987), 
pancreatoma cells (Horstman et. al, 1988) and adrenal chromaffin 
cells (Boksa, 1985). 
As shown in Table 3.9, SP (1 ~M) can increase [3HJ-inositol 
trisphosphate level in human astrocytoma cells (U-373 MG). There-
fore, SP-induced taurine release may be linked to an increase of 
[ca2+Ji which is mobilized by IP3 . Indeed, SP-induced [3HJ-tau-
rine release in medium devoid of extracellular calcium (CaCl 2-
free PSS containing 1 mM EGTA) was significantly lower than that 
in normal PSS (containing 3 mM CaCI 2 ) (Table 3.5) -. However, the 
magnitude of decrease in SP response was much less than that of 
A23187. This -may imply that the SP-induced [3HJ-taurine release 
was mediated by more than one second messenger and an increase in 
[ca2+Ji was only one of them. 
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The hydrolysis of PIP2 can generate Ins'(l,4,5)P3 and DAG. DAG 
, . 
activates PKC, which in its active form, is associated with the 
plasma membrane (Castagna et. al., 1982; Snolk et. al., 1988),. 
PKC activity has been demonstrated in , primary cultures of astro-
cytes (Neary et. al., 1986) and C6 glioma cells (Fishman et. aI, 
1987). Over 90% of PKC activity in astrocytes resides in the 
supernatant fraction and about 75% of this activity can be trans-
located to membranes upon treatment with PMA (Neary et. aI, 
1988). Mobley and coworkers (1986) suggested that PKC may play a 
role in the transformation of astrocytes from the immature, 
undifferentiated to a mature-like cell with processes since PMA 
(400 nM) can stimulate the transformation of cell morphology. In 
addition, considerable evidence from a number of cell types have 
indicated a role for PKC in secretion (Nishizuka, 1984; Shapira 
et. al., 1983). Activators of PKC have also been shown to affect 
the Ca 2+ sensitivity of secretory processes in various permeabi-
lized cells (Knight et. al., 1989) 
since 'PKC activation can be mediate directly by phorbol 
ester in the absence of phosphoinositide breakdown (Castagna et. 
al., 1982; Bazzi & Nelsestuen, 1989) I PMA was used in the 
present study to examine the effects of such activation on 
[3HJ-taurine release from human astrocytoma cells (U-373 MG) 
Initial experiment revealed that PMA increased the release of 
(3 H]-taurine release from astrocytom~ cell~ with an EC50 of 4 nM 
(Figure 3.16). Two PKC inhibitors, H7 and staurosporine were 
employed to define the role of PKC in [3HJ-taurine release. The 
results were unexpected since H7 (100 ~M) and staurosporine (10 
nM - 1 ~M) showed opposite effects on PMA-induced taurine release 
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from astrocytoma cells (Figure 3.16 and' 3.19). H7 (100 MM) 
potentiated the PMA response while staurosporine (10 nM to 1 MM) 
inhibited it. 
The ~eason for the opposite eff~cts of H7 and staurosporine 
is unclear. Both H7 and staurosporine have been identified as PKC 
inhibitor and exerted their actions by interfering with the 
interaction of ATP and protein substrate with the catalytic 
domain of PKC. H7 inhibit PKC by competition with ATP (Hidaka 
et. al., 1984). Since the structure of the ATP-binding site for 
all protein kinases is highly conserved, it is also an effective 
inhibitor for other protein kinases (Huang, 1989). On the other 
hand, staurosporine is a more. potent and specific inhibitor of 
PKC and it inhibits both the intact and proteolysed PKC as well 
as the cAMP-dependent protein kinase at nanomolar concentrations. 
It does not compete with ATP or other co factors of PKC (Huang, 
1989). It appears that staurosporine may interact directly with 
the catalytic domain of PKC to exert its effect (Tamaoki et. 
al., 1986). Both of these two inhibitors were found to inhibit 
the incorporation of r-32Pi to histone by PKC (Table 3.15) and 
the presence of PMA (100 nM) did not affect the inhibitory 
effect of staurosporine (1 MM) and H7 (100 MM). Thus, the oppo-
site effect of staurosporine and H7 on taurine release from 
astrocytoma cells cannot be attributed to a differential effect 
of these inhibitors on PKC. It is possible, however, that H7 may 
potentiate PMA action via its action on other protein kinases 
which is not shared by staurosporine. The presence result clearly 
suggests that caution must be exercised when interpreting the ~ 
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action of H7 as a PKC inhibitor. 
To be certain that PMA was releasing taurine via PKC activa-
tion and not by directly perturbing the membrane, it effect on 
astrocyotoma cells depleted of PKC . was studied. It has been 
demonstrated that after the treatment of PC12 pheochromocytoma 
cells with 1 ~M PMA for 24 h, PKC activity was decreased to 
background level in both particulate and cytoplasmic fractions. 
Analysis of cAMP- and ca2+/calmodulin-dependent kinases following 
chronic PMA treatment indicated no major changes in the activi-
ties of these enzymes (Matthies et. al., 1987). In the present 
study, the depletion of PKC was achieved by a nineteen hours 
incubation with 10 MM PMA (Table 3.14 and Figure 3.22). After 
this treatment PMA was unable to stimulate [3HJ-taurine release 
(Figure 3.22). This finding suggests that the PMA-induced taurine 
release is totally due to the activation of PKC by the phorbol 
ester. I 
It 
SP response was also partially inhibited after chronic PMA 
pretreatment (Figure 3.23). This suggests that the SP-induced 
[3HJ-taurine release was partly controlled by PKC while other 
second messengers, such as IP3 , may also be involved. It has been 
demonstrated that a down regulation of PKC by chronic PMA pre-
treatment can increase the production of Ins(1,4,5)P3 stimulated 
by bradykinin in neuroblastoma cells (Fu et. al., 1988). More-
over, chronic PMA pretreatment can ~ever~e the inhibitory effect 
of acute PMA pretreatment on carbachol-induced IP3 production in 
1321N1 astrocytoma cells (Brown et. al., 1987). These finding 
suggest the Ins(l,4,5)P3 production may be under inhibitory ~ 
control by PKC. There is some evidence that the effect of phorbol 
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ester and PKC on the phosphoinositide pathway may be at the level 
of G-protein. For instance, Gi has been shown to be a substrate 
of PKC (Katada et. al., 1985; sternweis & Pang, 1990). Therefore, 
after PMA pretreatment, some of the SP response may also be due 
to an exaggerated increase of IP3 level. This possibility remains 
to be studied. It should also be pointed out that most of the 
results implicating the role of [ca2+]i in regulating taurine 
release in the present study are indirect evidence-, a direct 
measurement of [ca2+Ji is necessary to confirm this conclusion. 
The effect of chronic PMA pretreatment on taurine release was 
rather specific as it did not affect the response of isoprotere-
nol, a ~-adrenergic agonist (Figure 3.24). 
A decrease of cellular taurine content after 12, 13-phorbol 
dibutyrate (PDBU) (1 ~M) and dbcAMP (1 mM) pretreatment for 24 h 
have been reported by Philibert and Dutton (1988). They suggested 
that this may be due to a net transport of taurine from the cells 
into the medium rather than net catabolism or anabolism of tau-
rine. The increase of [3HJ-taurine release by PMA and db cAMP 
observed in the present study (Figure 3.8 and 3.22) tend to 
support this hypothesis. The lower uptake of taurine after chron-
ic PMA pretreatment (Table 3.13) may be another explanation. 
PKC is a ca2+-activated, phospholipid-dependent protein 
kinase and is activated by unsaturated DAG which may be tran-
siently formed during the receptor-mediated hydrolysis of phos-
phatidylinositol. In addition, kinetic analysis indicates that 
DAG sharply increases the affinity of PKC for ca2+ and phospho-
lipid and thus initiates the selective activation of this protein ~ 
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kinase (Huang, 1989). 
SP stimulated the accumulation of IPs in human astrocytoma 
cells presumably as a result of hydrolysis of PIP2 . The hydroly-
sis of P1P2 will generate DAG which will intercalate in the 
cellular membrane and in combination with phospholipids will 
promote the translocation of the enzyme to. the membrane. This 
translocation from the cytosol to the membrane is associated with 
an activation of the enzyme (Kraft & Anderson, 1983). Indeed, SP 
was found to transiently stimulated the translocation of PKC 
activity in U-373 MG cells from the cytosol to the membrane 
(Figure 3.26). This finding also supports the notion that PKC 
activation may be one mechanism by which SP evoked its biological 
action in U-373 MG cells. 
Acute treatment of cells with phorbol ester or a DAG-generat-
ing agonist leads to the translocation of PKC from the cytoplasm 
to the particulate fraction (Kraft & Anderson, 1983). Prolonged 
treatment with phorbol ester or agonists which activate the 
enzyme then leads to the depletion of total cellular PKC activi-
ty over a period of 10-20 hr (Matthies et. al., 1987). PMA-in-
duced down regulation of PKC is caused by an accelerated rate of 
degradation of the PKC molecule (Young et. al., 1987). Degrada-
tion may involve proteolysis of membrane-bound PKC by ca2+-acti-
vated protease (Chidla et. al., 1986; Melloni et. al., 1985). 
After chronic PMA pretreatment , as ?hown _in Table 3.14, most of 
the cytosolic and membrane-bound PKC activity in human astrocyto-
ma cells are lost which may be due to the proteolysis of PKC. 
In addition to SP, IPR also stimulated the release of [3 HJ -
taurine (Figure 3.5) and the effect of IPR (100 nM) and SP (0.1 
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to 100 nM) were additive (Figure 3.6). 
It was also demonstrated that IPR and SP can stimulate cAMP 
and IPs accumulation respectively (Figure 3.3 and 3.7). Moreover, 
IPR did not affect the basal and SP-induced IPs accumulation 
(Figure 3.13). On the other hand, SP had no effect on the basal 
and IPR-induced cAMP accumulation (Figure 3.7). These results 
demonstrated that there were no interaction between ~-receptor 
and NK-1 receptor in stimulating the formation of cAMP and IPs. 
The effect of A23187 (1 MM) and IPR (100 nM) on [3H]-taurine 
release were also additive. Thus, the present result indicates 
that there was no cross-talk between adenylate cyclase/cAMP and 
IP3/ca
2+ pathway in their regulation of taurine release in U-373 
MG cells. This is quite unlike the situation reported in many 
other cell types where complex feedback loops exist between the 
adenylate cyclase/cAMP and IP/ca2+ pathways (Cooper et. al., 
1987; Meeker & Harden, 1982). 
Bearing in mind that U-373 MG cells are tumour cells, future 
studies should also be conducted in primary cultures of astro-
cytes in order to evaluate the physiological significance of this 
sP-induced [3 H]-taurine release. 
4.4 BIOLOGICAL SIGNIFICANCE OF SP-INDUCED TAURINE RELEASE 
Swelling of the brain following injury, after seizures, in 
stroke, and following neurosurgica~ procedures have been de-
scribed (Long, 1981). After brain injury, the astrocytic pocesses 
are greatly enlarged and pale, sugesting an accumUlation of fluid 
of low protein content. Oligodendrocytes are generally normal in 
appearance. Some dendritic swelling may occu~ but this is usually 
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a relatively minor finding, and neuronal cell bodies are virtual-
ly not changed at all from a structural standpoint. Late in the 
stages of edema, a characteristic glial scar develops. Thus, the 
importance. of astrocytes in regUlating brain water content is 
suggested by the close proximity of glial cells and cerebral 
blood vessels as well as the finding of astrocyte swelling in 
many disease states accompanied by cerebral edema (Voorhies et. 
al., 1983). 
Van Gelder and coworker (Van Gelder, 1983 ; 1989; Van Gelder 
& Barbear, 1985) have postulated that intraglial cell taurine 
controls central nervous system water balance by modulating 
astrocyte carbonic anhydrase and glutamate dehydrogenase activi-
ties. Taurine has also been described as an osmoregulator in the 
brain (Walz, 1987; Morales & Schousboe, 1988). Thurston and 
coworkers (1980) demonstrated that chronic hypernatremia dehydra-
tion induced by water deprivation and salt load~ng produced a 
marked increase in tissue amino acids content of mouse brain, 
with taurine accounting for over one-half of the total increase. 
Water deprivation in the Brattleboro rat with hereditary hypotha-
lamic diabetes insipidus also produced a clear increase in tau-
rine in skeletal muscles and in the brain (Nieminen et. al., 
1988). In addition, Wade and associates (1988) reported that an 
increase in cellular hydration in rat brains induced by hypo-
osmotic microdialysis or systemic water intoxication was accompa-
nied by a marked increase in extracellular taurine but not other 
amino acid levels. Therefore, it is possible that taurine is 
being used as an osmolite to be shuttled in and out of the cells ~ 
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in order to maintain their normal volume and intracellular osmo-
larity (Wade et. al., 1988). 
It has been reported that an increase in the plasma concen-
tration of SP can induce intestinal secretion of water and elec-
trolytes (McFadden et. al., 1986a, b). Whether SP has any osmo-
regulatory function in the eNS or not is unknown. However, it has 
been reported that after optic nerve transection, SP binding 
sites are expressed in high concentrations by cells comprising 
the glial scar in the optic nerve and optic tract (Mantyh et. 
al., 1989) .The function of these SP binding sites expressed by 
the astrocytes activated upon nerve injury remains undefined. In 
view of the present demonstration of increased taurine release 
upon SP receptor activation in U-373 MG cells, the possibility of 
SP can play a role in osmoregulation in the brain should be 
explored. 
Taurine has been proposed to be an inhibitory neuromodulator 
or neurotransmitter (Oja & Kontro, 1978). Much evidence support 
that most of the biological properties of taurine in excitable 
tissues are related to the regulation of the excitation threshold 
(van Gelder, 1983). It has been proposed that taurine can influ-
ence the tissue content of glutamic acid, glutamine, GABA, and 
aspartic acid by regulating neuronal glutamic acid retention (van 
Gelder, 1978). Some epileptic conditions represent a tendency for 
a chronic release of glutamic acid from neuronal structures (van 
Gelder, 1978; 1983) and taurine can provide neuroprotection 
against such conditions (Lehmann et. al., 1985). On the other 
hand, depletion of taurine in kittens during chronic hypernatrem-
ic dehydration has been reported to increase the frequency of 
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seizures activity (Barbeau et. al~, 1975) .~.Therefore, substance 
P-induced taurine release from astrocytes may also play a role in 




In the present study SP was demonstrated for the first time 
to stmulate the release of [3HJ-taurine from human astrocytoma 
(U-373 MG) cells. This effect was shared by the other mammalian 
tachykinins and the rank order of potency of tachykinins was SP 
» NKA» NKB. In addition, the potency of [Glp6, L-pr09 ]-SP(6-
11) was 180 times more active than [Glp6, D-pro9 J-SP(6-1l). This 
pharmacological profile conforms to that reported for the NK-l 
subtype of tachykinin receptors. The effect of SP was antagonised 
by spantide, a SP receptor antagonist, further supporting this 
being a receptor mediated event. 
Unlike neurons, the basal release of taurine from U-373 MG 
cells was calcium independent and was not increased by a depolar-
izing concentration of K+. The SP induced taurine release, howev-
er, was inhibited by K+ and by lowering extracellular Ca2+ lev-
els. The fact that A23l87 can stimulate [3HJ-taurine release in a 
calcium dependent manner provided an indirect evidence for the 
involvement of intracellular calcium level in the regulation of 
taurine release. 
Activation of NK-l receptors on astrocytoma cells by SP and 
NKA was shown to increase the accumulation of inositol phosphates 
including IP3 . The ECSOs of these peptides in stimulating the 
accumulation of IPs were very similar to that in stimulating the 
release of taurine. Moreover, spantide at 10-30 ~M, concentra-
tion- dependently inhibited the effect of SP on IPs accumulation. 
These results suggest that an activation of NK-l receptor by SP 
in human astrocytoma cells may increase intracellular Ca2+ level 
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and regulate taurine release via the formation of IP3 . The fact 
that A23187 can stimulate [3HJ-taurine release in a calcium 
dependent manner provided an indirect evidence for it. 
The ~ydrolysis of PIP2 can also generate DAG which in turn 
can activate PKC. Therefore, it was suspected that PKC may also 
play a role in the regulation of SP-induced taurine release. This 
was supported by the following observations: 
(1) SP-induced taurine release can be inhibited by staurospo-
rine, a potent PKC inhibitor; 
(2) the pretreatment of the cells with 10 MM PMA for 19 h can de-
crease SP-induced taurine release; 
(3) after 1 min exposure to SP "(lOO nM) I some PKC activity in 
the cytosolic fraction was translocate to the membrane-bound 
fraction. 
In addition to SP, IPR was also found to stimulate [3 H]-
taurine release but its response seemed to medi~ted by a cAMP 
pathway. It appeared that there was no cross-talk between the 
cAMP/adenylate cyclase and IP3/PLC pathway in the U-373 MG astro-
cytoma cells. Since IPR (100 nM) did not alter the basal and SP-
induced [3H]-inositol phosphates accumulation while SP (1 " MM) did 
not change the basal and IPR-induced cAMP accumulation. Moreover, 
chronic PMA pretreatment decreased SP-induced taurine release but 
not the IPR response. Both SP- and IPR- stimulated taurine re-
lease were additive which may further support the absence of 
cross-talk between two receptors. 
The major findings of this study are (1) the activation of 
NK-l subtype of tachykinin receptor by SP can stimulate the ~ 
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release of [3 H]-taurine from human astrocytoma (U-373 MG) cells; 
(2) NK-l receptor activation in astrocytoma ' cells are coupled to 
the hydrolysis of PIP2 and generates IP3 which in turn may in-
crease intracellular Ca2+ level and ~egulate taurine release; (3) 
SP can also regulate taurine release in U-373 MG cells via 
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